query,response,reference,correctness_score,semantic_similarity_score,answer_relevancy_score
What regulatory milestones has CytoSorb achieved in the United States?,"CytoSorb has received FDA approval for its device, CytoSorb, under the 510(k) pathway for the removal of inflammatory mediators from the blood of patients undergoing cardiopulmonary bypass surgery. The company has also achieved regulatory milestones through the FDA's Breakthrough Device designation for certain indications, supporting faster development and review for conditions such as sepsis and cytokine release syndrome. However, specific details about additional regulatory milestones in the U.S. may require up-to-date consultation with official FDA records or company disclosures.","CytoSorb has received FDA Breakthrough Designation for the removal of ticagrelor in a cardiopulmonary bypass circuit during emergent and urgent cardiothoracic surgery, and Emergency Use Authorization (EUA) for use in critically-ill patients with COVID-19 infection.",4.0,0.6448300480870773,1.0
What are the commercialization strategies for CytoSorb in different regions?,I don't know.,"CytoSorbents Corporation employs a mixed strategy of direct sales through its subsidiaries in key markets like Germany, Austria, and Switzerland, and distribution through strategic partners and independent distributors in other countries, leveraging CE Mark approval for European markets and actively seeking registrations worldwide.",1.0,0.24646564178638675,0.0
What are the financial implications of using CytoSorb in treating sepsis patients?,"The financial implications of using CytoSorb in treating sepsis patients include high upfront costs for the device, which may lead to increased hospital expenses. While some studies suggest potential reductions in ICU length of stay and overall healthcare costs due to improved outcomes, the overall cost-effectiveness remains debated. Insurance coverage and reimbursement policies vary, and the device is not universally covered, leading to potential out-of-pocket expenses for patients. More long-term economic studies are needed to fully assess the cost-benefit profile.","The use of CytoSorb in sepsis treatment is expected to improve clinical outcomes and reduce the need for costly ICU care, potentially saving significant healthcare costs. The therapy typically costs between $1,000 to $5,000, representing a fraction of the average cost of treating a severe sepsis patient, which can range from $45,000 to $60,000.",4.0,0.7947083294594715,1.0
What are the key risks associated with the discovery and development of our product candidates?,I don't know.,"The key risks include potential adverse impacts from COVID-19 on clinical trials, dependency on the success of lead product candidates, uncertainty of regulatory approval, and the high risk of failure in clinical trials.",1.0,0.22575807251679353,0.0
How does the COVID-19 pandemic affect our ability to conduct clinical trials?,"The COVID-19 pandemic has significantly disrupted clinical trials by causing delays in trial initiation, enrollment, and data collection due to restrictions on travel, healthcare facility closures, and the reallocation of medical resources to pandemic response. Site activations and monitoring visits have been delayed or modified through remote methods, and participant safety concerns have led to protocol amendments, such as telehealth visits or reduced in-person assessments. Additionally, supply chain interruptions have affected the delivery of investigational products, and regulatory agencies have had to adapt guidelines to accommodate these challenges. Despite these obstacles, the pandemic also accelerated innovations in remote monitoring and decentralized trial designs.","The COVID-19 pandemic may delay startup of new clinical trial sites, reduce patient enrollment, and disrupt operations of third-party suppliers and manufacturers, leading to delays or disruptions in the supply of product candidates for clinical trials.",5.0,0.6876536225762064,1.0
"What are the potential consequences of failing to comply with environmental, health, and safety laws and regulations?","Failing to comply with environmental, health, and safety laws and regulations can result in fines, penalties, legal action, and enforcement orders. It may also lead to reputational damage, loss of business licenses, increased insurance premiums, and potential criminal charges. Additionally, non-compliance can result in harm to employees, the public, and the environment, which could lead to costly cleanups, lawsuits, and long-term operational disruptions.","Non-compliance could result in fines, penalties, or increased costs associated with remediation, and could potentially harm our business operations and reputation.",5.0,0.7420334423528961,1.0
"How does the company's international operations expose it to additional risks, and what measures does it take to mitigate these risks?",I don't know.,"The company's international operations expose it to risks such as challenges caused by distance, language, and cultural differences, as well as varying legal, economic, and political conditions in different countries. To mitigate these risks, the company employs various strategies, including compliance with local laws and regulations, careful selection of markets, and diversification of operations across different jurisdictions.",1.0,0.1614445369970476,0.0
"What are the potential impacts of data privacy and security laws on the company's operations, and how does it ensure compliance with these regulations?","Data privacy and security laws can impact a company's operations by requiring changes to data collection, storage, and processing practices, increasing compliance costs, necessitating employee training, and imposing penalties for non-compliance. To ensure compliance, the company implements robust data protection policies, conducts regular risk assessments, appoints a Data Protection Officer if required, ensures data encryption and access controls, maintains audit trails, and stays updated on regulatory changes.","Data privacy and security laws, such as the GDPR and CCPA, impose stringent requirements on the collection, storage, and use of personal information, which could increase the company's costs and expose it to potential sanctions and lawsuits if not complied with. The company ensures compliance through implementing robust data protection measures, regular audits, and staying updated on regulatory changes to adapt its practices accordingly.",5.0,0.8416568883287784,1.0
"What was the total amount of revenue expected to be recognized from remaining performance obligations as of March 31, 2020?",I don't know.,"As of March 31, 2020, approximately $24.0 billion of revenue was expected to be recognized from remaining performance obligations.",1.0,0.26199018796609097,0.5
What were the major elements contributing to the difference between the U.S. federal statutory tax rate and the effective tax rate in fiscal 2020?,"The major elements contributing to the difference between the U.S. federal statutory tax rate and the effective tax rate in fiscal 2020 include:  
1. **Tax deductions and credits** (such as the research and development tax credit and the foreign tax credit),  
2. **Tax deferrals** (especially from foreign operations under the Tax Cuts and Jobs Act of 2017),  
3. **Accounting for temporary differences** (e.g., depreciation methods, revenue recognition),  
4. **Use of tax-loss carryforwards** and other tax attributes,  
5. **Expenses that are not deductible for tax purposes** (such as certain executive compensation), and  
6. **International tax planning**, including income deferral and transfer pricing strategies.  

These factors reduce the effective tax rate below the statutory rate of 21% in 2020.","The major elements contributing to the difference in fiscal 2020 included a non-deductible goodwill impairment charge, a non-taxable gain on an arbitration award, a change in the net valuation allowance on certain deferred tax assets, and an increase in Income Tax and Foreign Tax Credits.",3.0,0.6171661131125877,1.0
How did the Company's annual goodwill impairment analysis in fiscal 2020 differ from previous years?,I don't know.,"In fiscal 2020, the Company performed quantitative goodwill impairment tests during the second and fourth quarters due to a sustained decline in the Company’s stock price and market capitalization, leading to the recognition of total non-cash impairment charges of $6,794 million. This was a departure from previous years where no such impairments were recognized.",1.0,0.2389662257024684,0.0
How did the Company's approach to managing foreign currency risk through derivative instruments evolve in fiscal 2020?,I don't know.,"The Company continued to use foreign currency forward contracts as cash flow hedges to reduce foreign currency risk related to certain intercompany obligations and forecasted transactions. The notional amounts of these contracts designated as cash flow hedges increased to $455 million as of March 31, 2020, from $277 million as of March 31, 2019.",1.0,0.19611029499212843,0.0
"How does the company plan to commercialize its product candidates, and what are the associated risks?",I don't know.,"The company plans to directly market and commercialize its product candidates by developing its own sales and marketing force. The associated risks include the potential for increased expenses, the inability to hire and retain qualified personnel, and the possibility of failing to build a successful commercial infrastructure.",1.0,0.21224016564748024,0.0
What are the potential impacts of the COVID-19 pandemic on the company's business operations?,I don't know.,"The COVID-19 pandemic could disrupt the company's preclinical studies, clinical trials, and operations, potentially leading to delays in patient enrollment, difficulties in conducting trials, and interruptions in the supply chain for its product candidates.",1.0,0.2662072380188259,0.0
How does the company's reliance on third-party contract manufacturing organizations (CMOs) impact its operations?,"The company's reliance on third-party contract manufacturing organizations (CMOs) can impact its operations in several ways:

1. **Cost Efficiency**: Outsourcing manufacturing can reduce capital expenditures and fixed costs associated with owning and operating production facilities, allowing the company to allocate resources to other strategic areas.

2. **Scalability**: CMOs enable the company to scale production rapidly in response to demand fluctuations without significant investment in infrastructure.

3. **Focus on Core Competencies**: By delegating manufacturing to specialized CMOs, the company can concentrate on research, development, marketing, and distribution.

4. **Supply Chain Complexity**: Reliance on external partners may introduce risks related to supply chain disruptions, quality control, and production delays.

5. **Intellectual Property (IP) Risks**: Sharing proprietary processes or formulations with CMOs can expose the company to IP theft or misappropriation, especially if contracts and non-disclosure agreements are not robust.

6. **Quality Control and Compliance**: The company must ensure that CMOs adhere to regulatory standards (e.g., GMP) and maintain consistent product quality, which may require significant oversight and auditing.

7. **Geographic and Regulatory Challenges**: Operating with CMOs in different countries may lead to challenges related to differing regulatory requirements, logistics, and trade regulations.

8. **Dependency and Flexibility**: Over-reliance on a limited number of CMOs can reduce negotiating power and increase vulnerability to supply chain disruptions.

In summary, while leveraging CMOs can enhance operational efficiency and flexibility, it also introduces risks related to control, quality, and supply chain resilience.","The company's reliance on CMOs exposes it to risks such as supply chain disruptions, potential manufacturing defects, and the inability to quickly transition to alternative suppliers if needed, which could delay product development and commercialization.",4.5,0.7231345847648023,1.0
What are the potential consequences of the company's failure to comply with healthcare laws and regulations?,"The potential consequences of a company's failure to comply with healthcare laws and regulations include fines, penalties, legal action, loss of licenses or certifications, reputational damage, and potential criminal charges. Non-compliance may also lead to increased scrutiny from regulatory agencies and mandatory corrective actions.","Failure to comply with healthcare laws and regulations could result in significant legal, financial, and reputational harm, including the imposition of civil, criminal, and administrative penalties, damages, monetary fines, and potential exclusion from participation in government healthcare programs.",5.0,0.8840443187542757,1.0
What are the risks associated with the company's reliance on collaborations and licensing arrangements?,I don't know.,"The company's reliance on collaborations and licensing arrangements exposes it to risks such as the potential for partners to shift priorities, terminate agreements, or fail to fulfill their obligations, which could delay or prevent the development and commercialization of its product candidates.",1.0,0.2706039346141089,0.0
What are the potential benefits of intrathecal administration of AAV9-based gene therapies?,"The potential benefits of intrathecal administration of AAV9-based gene therapies include targeted delivery to the central nervous system (CNS), improved transduction of neurons and glial cells in the spinal cord and brain, reduced systemic exposure (minimizing off-target effects), enhanced therapeutic efficacy for neurological disorders, and the ability to treat conditions affecting the CNS with potentially lower vector doses compared to systemic administration. This route is particularly promising for diseases such as spinal muscular atrophy, certain lysosomal storage disorders, and other inherited neurological conditions.","The potential benefits of intrathecal administration of AAV9-based gene therapies include optimal biodistribution and cell transduction within the CNS, administration even in the presence of pre-existing antibodies to AAV, and limited exposure to peripheral organs.",5.0,0.8510853590548737,1.0
How does the company plan to finance its cash needs in the future?,I don't know.,"The company plans to finance its cash needs through a combination of equity offerings, government or private party grants, debt financings, and license and collaboration agreements.",1.0,0.18784888507425207,1.0
What are the risks associated with the company's reliance on third-party suppliers for materials used in the manufacture of its product candidates?,I don't know.,"Risks include limited control over pricing, availability, and quality of materials, potential supply interruptions, and increased costs if alternative suppliers need to be found, which could delay clinical trials and commercialization efforts.",1.0,0.24528138086089107,0.0
How does the company's dependence on collaboration with UT Southwestern affect its research and development programs?,I don't know.,The company's dependence on UT Southwestern for preclinical research and development programs could lead to delays or failures in its development efforts if UT Southwestern fails to fulfill its obligations or if there is a breakdown in collaboration.,1.0,0.24413778934679445,0.0
"How did the adoption of ASC Topic 842 affect the Company's Consolidated Balance Sheets as of August 3, 2019?",I don't know.,The adoption of ASC Topic 842 resulted in the recognition of operating lease liabilities with corresponding right-of-use assets of approximately the same amount based on the present value of the remaining lease payments for existing operating leases.,1.0,0.2247871901412795,0.0
How did the Company account for the Supervalu acquisition in terms of goodwill and intangible assets?,I don't know.,"In conjunction with the Supervalu acquisition, goodwill resulting from the acquisition was assigned to the previous Supervalu Wholesale reporting unit and the legacy Company Wholesale reporting unit. Identifiable intangible assets were also recorded based on final valuations, with expected useful lives ranging from 5 to 20 years.",1.0,0.2382183414287763,0.0
How did the Company's defined benefit pension plans perform in fiscal 2020 in terms of contributions and obligations?,I don't know.,No minimum pension contributions were required to be made under either the SUPERVALU INC. Retirement Plan or the Unified Grocers pension plan in fiscal 2020. The Company expected to contribute approximately $0.0 million to $5.3 million to its other defined benefit pension plans and postretirement benefit plans in fiscal 2021.,1.0,0.26122314152662846,0.0
How did the adoption of the CARES Act affect the Company's deferred tax assets and liabilities?,I don't know.,"The CARES Act allowed the Company to carry back net operating losses, resulting in a tax benefit of approximately $39.5 million. This was recorded as a current tax receivable in the Consolidated Balance Sheet as of August 1, 2020.",1.0,0.15227168716663256,0.0
How did the Company's decision to reclassify Retail operations from discontinued to continuing operations affect the financial statements?,I don't know.,"The reclassification resulted in the inclusion of Retail’s results of operations, financial position, and cash flows within continuing operations for all periods, affecting the presentation but not the underlying financial performance or position.",1.0,0.23893965123506275,0.0
"What was the total net revenue for Quest Diagnostics in 2020, and how did it compare to the previous year?",I don't know.,"The total net revenue for Quest Diagnostics in 2020 was $9.4 billion, which was up 22.1% from the previous year.",1.0,0.2603080408615777,0.0
How did the COVID-19 pandemic impact Quest Diagnostics' testing volume and revenues in 2020?,"In 2020, the COVID-19 pandemic significantly increased Quest Diagnostics' testing volume and revenues. The company saw a substantial surge in demand for COVID-19 testing, which led to a substantial rise in both testing volumes and revenue. In 2020, Quest Diagnostics reported a net revenue increase of 39% compared to the previous year, largely driven by the demand for COVID-19 testing. The company processed millions of tests throughout the year, contributing to its financial growth during the pandemic.","The COVID-19 pandemic led to a decline in testing volume in Quest Diagnostics' base business by 11.4% in 2020, but this was more than offset by increased demand for COVID-19 molecular and antibody testing, which drove a 23.4% increase in revenues in the DIS business.",3.0,0.8229823976660916,1.0
How did Quest Diagnostics' capital expenditures and investments in technology and infrastructure evolve in 2020?,I don't know.,"Quest Diagnostics invested approximately $350 million to $400 million in capital expenditures in 2020, focusing on investments in information technology, laboratory equipment and facilities, including COVID testing equipment, and completion of a new multi-year laboratory construction in New Jersey.",1.0,0.2853344127005266,0.0
"What were the key financial covenants associated with Quest Diagnostics' credit facilities, and how were they amended in 2020?",I don't know.,"The key financial covenant associated with Quest Diagnostics' credit facilities was the maintenance of a financial leverage ratio. In 2020, the Company amended the Credit Facility to provide increased covenant flexibility, increasing the leverage ratio covenant temporarily to provide more flexibility during the COVID-19 pandemic.",1.0,0.2302009489516845,0.0
What are the primary risks related to the company's financial condition and capital requirements?,I don't know.,"The company faces risks including a limited operating history, significant ongoing losses, and the need for additional funding to expand commercialization and development efforts. Failure to obtain necessary capital could force the company to delay or terminate product commercialization or development efforts.",1.0,0.3091371462759483,0.0
How does the company's reliance on a single supplier for key components impact its operations?,"The company's reliance on a single supplier for key components can increase operational risk, as it creates vulnerability to supply chain disruptions, price fluctuations, and quality issues. Any delay, shortage, or failure from that supplier can halt production, lead to customer dissatisfaction, and damage the company's reputation. Additionally, it may reduce the company's negotiating power and limit flexibility in responding to market changes.","The company's reliance on a single supplier, TSMC, for manufacturing and supplying wafers used in its probes poses a risk if TSMC fails to fulfill obligations or performs unsatisfactorily. This could negatively affect the company's ability to source its devices and potentially impact cash flows due to minimum purchase obligations.",4.0,0.6845851593226736,1.0
What are the cybersecurity risks associated with the company's operations?,I don't know.,"The company faces risks of cybersecurity incidents that could result in unauthorized access, data breaches, or operational disruptions, potentially leading to harm to customers, business interruptions, legal liabilities, reputational damage, and increased costs for remediation and protection.",1.0,0.3093180665806022,0.0
What are the risks associated with the company's reliance on open source software?,I don't know.,"Using open source software may expose the company to risks such as requirements to disclose source code, potential infringement claims, and the possibility that competitors could use the same open source software to create similar products. Failure to comply with open source licenses could restrict the company's ability to sell its products and lead to legal challenges.",1.0,0.22412026500670268,0.0
How does Brandywine Realty Trust account for acquisitions of real estate that do not meet the definition of a business?,"Brandywine Realty Trust accounts for acquisitions of real estate that do not meet the definition of a business as asset acquisitions. Under such circumstances, the purchase price is allocated to the individual assets acquired and liabilities assumed based on their fair values at the acquisition date. The difference between the purchase price and the fair value of the net assets acquired is recognized as goodwill or a gain, depending on the circumstances. This approach is consistent with the accounting treatment under U.S. GAAP for non-business acquisitions.",Acquisitions of real estate that do not meet the definition of a business are accounted for as asset acquisitions. The acquisition consideration (including acquisition costs) is allocated to the individual assets acquired and liabilities assumed on a relative fair value basis.,4.5,0.7975673798469362,1.0
What method does Brandywine Realty Trust use to depreciate its buildings and improvements?,Brandywine Realty Trust uses the straight-line method to depreciate its buildings and improvements over their estimated useful lives.,Brandywine Realty Trust uses the straight-line method to depreciate its buildings and improvements over lives ranging from the life of the lease to 55 years.,4.0,0.9652721090328519,1.0
How does Brandywine Realty Trust determine the fair value of its real estate investments for impairment assessments?,"Brandywine Realty Trust determines the fair value of its real estate investments for impairment assessments by considering various factors, including current market conditions, recent comparable sales, rental rates, vacancy rates, and cash flow projections. The fair value is typically estimated using discounted cash flow models and, when available, observable market data such as recent sales of comparable properties. This process ensures that the impairment assessment reflects the current market value and economic conditions of the real estate assets.","Brandywine Realty Trust determines the fair value of its real estate investments for impairment assessments using estimated undiscounted future cash flows expected to be generated from the operations and eventual disposition of the assets over, in most cases, a 10-year hold period. The estimates consider assumptions including market rental rates, capitalization rates, and recent sales data for comparable real estate investments.",4.5,0.8815157483251612,1.0
What are the key factors considered by Brandywine Realty Trust in its assessment of whether to consolidate a variable interest entity (VIE)?,"Brandywine Realty Trust considers the following key factors in assessing whether to consolidate a variable interest entity (VIE):

1. **Power over the entity**: Whether Brandywine has the ability to direct the activities that most significantly impact the VIE’s economic performance.
2. **Exposure to losses or rights to benefits**: Whether Brandywine has the obligation to absorb significant losses or the right to receive significant benefits from the VIE.
3. **Significant influence**: The extent to which Brandywine can influence or control the VIE’s operations and financial outcomes.
4. **Nature of the entity’s activities and structure**: The specific operations, business model, and legal structure of the VIE.
5. **Contractual arrangements**: Any agreements (e.g., management, lease, or service contracts) that grant Brandywine control over the VIE’s operations.
6. **Lack of independent investor**: Whether the VIE lacks third-party investors with a material financial interest or influence.

These considerations align with the guidance under Accounting Standards Codification (ASC) 810, which governs consolidation of VIEs.","Brandywine Realty Trust considers whether it is the primary beneficiary of a VIE, which involves having both the power to direct the activities that most significantly impact the VIE's economic performance and the obligation to absorb losses or the right to receive benefits of the VIE that could potentially be significant to the VIE.",4.0,0.732689407208231,1.0
How has the COVID-19 pandemic impacted the company's underwriting results in 2020?,I don't know.,"The COVID-19 pandemic significantly impacted the company's underwriting results in 2020 by causing an underwriting loss due to pandemic-related catastrophe losses, which included event cancellation coverage for conferences and sporting events, business interruption claims, and related estimated legal expenses.",1.0,0.2596187008550769,0.0
What measures has the company taken to mitigate the impact of catastrophe events?,I don't know.,"The company has taken several measures to mitigate the impact of catastrophe events, including considering catastrophe risks in underwriting and pricing decisions, purchasing reinsurance, monitoring and modeling accumulated exposures, and managing exposure in key geographic zones and product lines prone to catastrophe events.",1.0,0.22534914607676823,0.0
"How does the company account for prior accident year loss reserve development, and what impact does it have on financial results?","The company accounts for prior accident year loss reserve development by adjusting its loss reserves based on changes in estimates of future claim payments. These adjustments reflect new information such as actual claim experience, changes in litigation trends, or economic factors. 

When loss reserves are increased (i.e., more reserves are needed), it results in a higher loss expense, which reduces net income. Conversely, if loss reserves are decreased (i.e., fewer reserves are needed), it leads to lower loss expenses and an increase in net income.

This development impacts financial results directly, as it affects the reported profitability and can influence the company's financial ratios and regulatory capital. It also provides insight into the accuracy of the company's underwriting and pricing assumptions.","The company accounts for prior accident year loss reserve development by periodically analyzing and adjusting the expected ultimate cost of liabilities to reflect favorable or unfavorable development in loss experience and new information. Adjustments to these reserves, both favorable and unfavorable, are reflected in the financial results of the periods in which these adjustments are made.",4.5,0.6764740565123902,1.0
"What is the role of non-GAAP financial measures in the company's financial analysis, and how are they reconciled with GAAP measures?","Non-GAAP financial measures are used by companies to provide additional insight into their operational performance by excluding certain items that management believes are not indicative of ongoing core business results. These measures can include adjustments for one-time charges, stock-based compensation, or other non-cash expenses. They are often used to enhance understanding of a company’s underlying performance trends.

However, because non-GAAP measures are not standardized and can be presented in various ways, they must be reconciled to the most directly comparable GAAP (Generally Accepted Accounting Principles) measures. This reconciliation typically includes a table or schedule that shows the GAAP financial result and then adjusts it to arrive at the non-GAAP measure, clearly disclosing the nature and amount of each adjustment. This allows investors and analysts to understand how the non-GAAP figures were derived and to compare them appropriately with GAAP figures.","Non-GAAP financial measures, such as underwriting profit and adjusted earnings before income taxes, provide additional information to investors and analysts by highlighting specific aspects of performance that management believes are meaningful. These measures are not a substitute for GAAP measures and are reconciled with the most comparable GAAP financial measures in the financial statements.",5.0,0.6747445203670422,1.0
How has the company's capital structure and liquidity position been managed to support its operations during the financial year 2020?,I don't know.,"The company has managed its capital structure and liquidity position by maintaining a relatively liquid financial position at its unrestricted holding companies, issuing new senior notes, and utilizing credit facilities. These measures have ensured adequate funds for operational needs, including acquisitions and share repurchases, despite challenges posed by the COVID-19 pandemic.",1.0,0.17473322574967212,0.0
What are the key assumptions used in the valuation of Huntington Bancshares Incorporated's mortgage servicing rights (MSRs)?,"The key assumptions used in the valuation of Huntington Bancshares Incorporated's mortgage servicing rights (MSRs) typically include:

1. **Prepayment Speeds (e.g., PSA or CPR):** Assumptions about how quickly borrowers are expected to prepay their mortgages, which affects the cash flows from servicing fees and the value of future servicing income.

2. **Discount Rate:** The rate used to discount future expected cash flows to their present value, reflecting the time value of money and risk.

3. **Servicing Fee Rates:** Assumptions about the fee income earned from servicing the loans, including contractual and actual servicing margins.

4. **Cost of Servicing:** Estimates of the ongoing expenses associated with servicing the mortgage portfolio, such as customer service, payment processing, and compliance.

5. **Default Rates:** Assumptions about the likelihood of borrowers defaulting on their loans, which affects the amount of servicing income and potential credit losses.

6. **Recovery Rates:** Assumptions about the percentage of mortgage balance recovered in the event of default or foreclosure.

7. **Economic Environment:** Macro-level assumptions about interest rates, housing prices, and economic conditions, which influence prepayment and default behavior.

8. **Servicing Mix:** Assumptions about the proportion of loans that are refinanced, prepaid, or charged off, which impacts the life cycle of the MSR.

These assumptions are typically based on historical performance, market conditions, and internal modeling, and are subject to change based on economic trends and regulatory updates.","The key assumptions used in the valuation of Huntington Bancshares Incorporated's MSRs include the discount rate, prepayment speed, and the servicing fee. These assumptions are used in a discounted future cash flow model to estimate the fair value of MSRs.",5.0,0.9017342241253853,1.0
What is the significance of the allowance for credit losses (ACL) in the context of Huntington Bancshares Incorporated's financial reporting?,"The allowance for credit losses (ACL) is significant in Huntington Bancshares Incorporated's financial reporting as it represents management's estimate of expected credit losses on financial assets, such as loans and leases. This allowance is a key component of the bank's financial health, reflecting its assessment of potential loan defaults and impairments. By maintaining an adequate ACL, Huntington complies with accounting standards (such as ASC 326, CECL) that require proactive recognition of credit losses, ensuring that its financial statements provide a realistic and transparent view of its credit risk exposure. A higher ACL may indicate greater perceived risk, while a well-managed ACL reflects sound credit risk management and contributes to the stability and confidence in the bank's financial position.","The allowance for credit losses (ACL) is significant in Huntington Bancshares Incorporated's financial reporting as it represents the amount set aside to cover potential credit losses on financial assets measured at amortized cost, including loan receivables and held-to-maturity debt securities. The ACL is deducted from the amortized cost basis of a financial asset or a group of financial assets so that the balance sheet reflects the net amount Huntington expects to collect.",4.5,0.9037103850268625,1.0
How does Huntington Bancshares Incorporated manage its interest rate risk through derivative financial instruments?,I don't know.,"Huntington Bancshares Incorporated manages its interest rate risk through the use of derivative financial instruments, principally interest rate swaps, caps, floors, and collars. These instruments provide flexibility in adjusting Huntington’s sensitivity to changes in interest rates without exposure to loss of principal and higher funding requirements. They are used in asset and liability management activities to protect against the risk of adverse price or interest rate movements.",1.0,0.14355986169105633,0.0
What was the total acquisition-date fair value of consideration transferred in the Sprint Merger?,I don't know.,The total acquisition-date fair value of consideration transferred in the Sprint Merger was $40.8 billion.,1.0,0.2759422689879215,1.0
How much did T-Mobile pay in Commitment Letter fees to certain financial institutions in connection with the Merger?,I don't know.,T-Mobile paid $355 million in Commitment Letter fees to certain financial institutions in connection with the Merger.,1.0,0.2604375853393779,1.0
"What was the impact of the new credit loss standard on the allowance for credit losses as of January 1, 2020?","The new credit loss standard, ASC 326 (Current Expected Credit Loss or CECL), required financial institutions to recognize allowances for credit losses based on expected losses over the life of the financial asset, rather than waiting for a loss to be probable (as under the previous incurred loss model). As of January 1, 2020, the impact was that financial institutions had to adopt this new standard, resulting in a significant increase in allowance for credit losses for many institutions, particularly in the banking sector, due to the forward-looking nature of the CECL model. The exact impact varied by institution depending on their loan portfolio, risk profile, and economic forecasts.","The new credit loss standard resulted in an increase to the allowance for credit losses of $91 million as of January 1, 2020.",4.0,0.6520878697003047,1.0
"What was the total principal amount of Senior Secured Notes issued by T-Mobile USA on April 9, 2020?",I don't know.,"The total principal amount of Senior Secured Notes issued by T-Mobile USA on April 9, 2020 was $19.0 billion.",1.0,0.25625784066831253,1.0
What are the primary risks associated with investing in the shares of the company as outlined in the financial report?,I don't know.,"The primary risks include the company's lack of an operating history, potential for significant fluctuations in quarterly results, and the risk of not achieving investment objectives due to market conditions and competition.",1.0,0.3154414356368002,0.0
How does the company's status as a non-diversified investment company under the 1940 Act affect its investment strategy?,"The company's status as a non-diversified investment company under the 1940 Act allows it to invest a larger portion of its assets in a smaller number of issuers, meaning it is not required to maintain the same level of diversification as a diversified fund. This enables the company to pursue more concentrated investment strategies, potentially leading to higher returns but also higher risk.","As a non-diversified investment company, the company is not limited in the proportion of assets it may invest in securities of a single issuer, which may increase the volatility of its NAV and make it more susceptible to economic or regulatory occurrences.",4.5,0.7561722398667171,1.0
What measures does the company take to mitigate the risk of unrealized losses on its portfolio?,I don't know.,"The company values its investments at market value or fair value as determined in good faith by its Board of Trustees, considering various factors such as the estimated enterprise value of a portfolio company, the nature and realizable value of collateral, and the portfolio company’s ability to make payments based on its earnings and cash flow.",1.0,0.24338737343597192,0.0
How does the company plan to address the risk of fluctuations in interest rates affecting its cost of capital and net investment income?,I don't know.,"The company may use interest rate risk management techniques, including various interest rate hedging activities to the extent permitted by the 1940 Act, to limit its exposure to interest rate fluctuations.",1.0,0.22731144555175709,0.0
What are the potential consequences if the company fails to maintain its status as a Business Development Company (BDC)?,"If a company fails to maintain its status as a Business Development Company (BDC), it may lose the tax advantages associated with that status, including the ability to avoid corporate income tax on income that is properly distributed to shareholders. Additionally, the company may face limitations in raising capital through public offerings or debt issuance, and it could be subject to greater regulatory scrutiny or penalties. Loss of BDC status could also impact investor confidence and the company's ability to operate efficiently as a private equity or debt financing firm.","If the company fails to maintain its BDC status, it could be regulated as a registered closed-end investment company under the 1940 Act, subjecting it to more regulatory restrictions and potentially decreasing its operating flexibility.",4.0,0.6690786066260425,1.0
How does the company manage the risk of default by portfolio companies on their debt obligations?,I don't know.,The company may incur expenses to seek recovery upon default or to negotiate new terms with defaulting portfolio companies. It also relies on the investment expertise and network of business contacts of the Adviser and its affiliates to monitor and service its investments.,1.0,0.24490229980718087,0.0
What are the implications of Intec Israel being characterized as a passive foreign investment company (PFIC) for U.S. shareholders?,"If Intec Israel is characterized as a Passive Foreign Investment Company (PFIC), U.S. shareholders may face significant tax implications. These include:

1. **Adverse U.S. Tax Treatment**: Income and gains from PFICs are taxed under the PFIC rules, which can result in higher effective tax rates compared to ordinary U.S. investment income.

2. **Excess Distribution Rules**: Distributions from a PFIC are treated as ordinary income and may be subject to special taxation, including interest charges on deferred taxes.

3. **Annual Mark-to-Market Election (if applicable)**: If a U.S. shareholder makes the mark-to-market election, they may be subject to current ordinary income treatment on unrealized gains, though this may not eliminate all PFIC penalties.

4. **Penalties for Non-Compliance**: Failure to make required elections (e.g., the QEF or mark-to-market election) may result in additional tax and interest charges.

5. **Complex Reporting Requirements**: U.S. shareholders must file Form 8621 to report their PFIC investments and associated income or gains.

6. **Deferral and Interest Charges**: Deferred taxes on gains and distributions are subject to interest charges, effectively increasing the tax burden over time.

These rules can significantly reduce the after-tax return for U.S. investors in a PFIC like Intec Israel. It is advisable to consult a tax professional to evaluate potential elections and compliance requirements.","U.S. shareholders of a PFIC may face adverse tax consequences, including having gains classified as ordinary income, loss of preferential tax rates on dividends, and application of interest charges to distributions and share sales.",5.0,0.7141399143370483,1.0
How did the adoption of the Current Expected Credit Loss (CECL) model affect the Company's financial statements in 2020?,I don't know.,"Upon adoption of CECL on January 1, 2020, the Company recorded a cumulative effect adjustment to decrease retained earnings by $25,018, with corresponding adjustments to the allowance for credit losses on loans and unfunded commitments.",1.0,0.21917292364310165,0.0
What significant mergers and acquisitions did FB Financial Corporation complete in 2020?,I don't know.,"FB Financial Corporation completed mergers with Franklin Financial Network, Inc. on August 15, 2020, and FNB Financial Corp. on February 14, 2020.",1.0,0.1876008620666857,0.0
How did the Company's allowance for credit losses change in 2020 due to the acquisitions of Franklin and FNB Financial Corp.?,I don't know.,"The acquisitions of Franklin and FNB Financial Corp. increased the allowance for credit losses by $77,653 and $4,494, respectively, as of their acquisition dates.",1.0,0.22075729334074537,0.0
"What was the impact of the PPP loans on the Company's loan portfolio as of December 31, 2020?",I don't know.,"As of December 31, 2020, the Company had $212,645 of loans originated as part of the PPP, which are federally guaranteed and have minimal credit risk associated with them.",1.0,0.2621032637310417,0.0
How did the Company's investment in Federal Home Loan Bank (FHLB) stock affect its financial position?,I don't know.,"The Bank accounts for its investments in FHLB stock at cost and evaluates them for impairment. As of December 31, 2020, the investment in FHLB stock was carried at cost and evaluated for impairment.",1.0,0.2418696820525996,0.0
What were the quarterly earnings per share (EPS) for FB Financial Corporation in 2020?,I don't know.,"The quarterly EPS for FB Financial Corporation in 2020 were as follows: Q1 - $0.71, Q2 - $0.95, Q3 - $1.00, and Q4 - $1.11.",1.0,0.20439064707459514,0.5
How does the ongoing COVID-19 pandemic potentially affect the company's operations?,I don't know.,"The COVID-19 pandemic could materially affect the company's operations, including clinical development, sales and marketing efforts, supply chain operations, research and development activities, and fundraising activities, potentially leading to delays or disruptions.",1.0,0.28464272849907896,0.0
How does the company's reliance on third-party manufacturers for the production of its product candidates pose risks?,"The company's reliance on third-party manufacturers for the production of its product candidates poses several risks, including potential supply chain disruptions, quality control issues, and intellectual property concerns. Third-party manufacturers may face production delays, capacity constraints, or regulatory non-compliance, which could impact the timely availability of products. Additionally, the company may have limited control over manufacturing processes, potentially leading to inconsistencies in product quality or scalability. Dependence on external partners can also result in higher costs or reduced flexibility in responding to market demands. Finally, reliance on third-party manufacturers may expose the company to risks related to confidentiality and the protection of proprietary manufacturing processes.","Reliance on third-party manufacturers carries risks such as potential breaches of manufacturing agreements, termination of agreements, reliance on the third party for regulatory compliance, quality assurance, and potential supply disruptions.",4.5,0.7151703320544375,1.0
What are the potential impacts of the company's limited operating history as a pharmaceutical company?,I don't know.,"The company's limited operating history makes it difficult to evaluate its future success and viability, and it may encounter risks and difficulties frequently experienced by early-stage pharmaceutical companies, which could adversely affect its business, operating results, and financial condition.",1.0,0.3396903857180276,0.0
How does the company's status as an emerging growth company and a smaller reporting company affect its disclosure requirements?,"As an emerging growth company and a smaller reporting company, the firm is eligible for reduced disclosure requirements. Specifically, it is exempt from the auditor attestation requirements of Section 404(b) of the Sarbanes-Oxley Act, has reduced disclosure obligations regarding executive compensation and corporate governance, and is not required to provide a detailed report on its internal control over financial reporting. Additionally, it may choose to reduce the number of financial statements and related disclosures required in its periodic reports. These exemptions are designed to lessen the regulatory burden on smaller, growing companies.","As an emerging growth company and a smaller reporting company, the company is permitted to rely on exemptions from certain disclosure requirements, which may make its common stock less attractive to investors and could affect the trading price of its stock.",5.0,0.7557902783512384,1.0
How did the COVID-19 pandemic impact VF's financial position as of March 2020?,I don't know.,The COVID-19 pandemic led VF to draw down $1.0 billion from its Global Credit Facility to strengthen its cash position and support general working capital needs.,1.0,0.24391156050213747,0.0
"What was the total amount of cash flow hedges used by VF as of March 2020, and how much was expected to be reclassified to earnings within the next 12 months?",I don't know.,"VF had $60.2 million of pre-tax net deferred gains for foreign currency exchange contracts in accumulated OCI as of March 2020, of which $60.2 million was expected to be reclassified to earnings within the next 12 months.",1.0,0.1750657191578451,0.0
How does the COVID-19 pandemic impact the company's commercial launch of TAZVERIK?,I don't know.,"The COVID-19 pandemic has limited the company's ability to access accounts and healthcare professionals, negatively impacted patient visits to physicians, and continued to disrupt commercialization efforts, which could result in adverse effects on the business and operations.",1.0,0.30243542512904925,0.0
What are the financial implications of the company's reliance on third-party manufacturers for the production of tazemetostat?,I don't know.,"Reliance on third-party manufacturers increases the risk of not having sufficient quantities of tazemetostat or such quantities at an acceptable cost or quality, which could delay, prevent, or impair development or commercialization efforts.",1.0,0.24348535416809022,0.0
How does the company's intellectual property portfolio affect its competitive position?,"A company's intellectual property (IP) portfolio can enhance its competitive position by providing legal protection for innovations, enabling market differentiation, and creating barriers to entry for competitors. Strong IP rights, such as patents, trademarks, copyrights, and trade secrets, allow the company to maintain exclusivity over its products, technologies, or brands, which can lead to higher market share, increased revenue, and stronger bargaining power. Additionally, a robust IP portfolio can attract investors and facilitate partnerships or licensing agreements.","The company's ability to protect its intellectual property rights is crucial for maintaining a competitive edge. Failure to obtain, maintain, and enforce patent protection could allow competitors to develop and commercialize similar products, adversely affecting the company's business.",5.0,0.5352812773225845,1.0
What are the risks associated with the company's reliance on collaborations for product development and commercialization?,I don't know.,"Risks include collaborators' discretion in determining resource allocation, potential de-emphasis or termination of development programs, and the possibility of disagreements over proprietary rights or contract interpretation, which could adversely affect the company's business.",1.0,0.2299849457403949,0.0
What are the four reportable operating segments of Willis Towers Watson?,I don't know.,"The four reportable operating segments are Human Capital and Benefits (HCB), Corporate Risk and Broking (CRB), Investment, Risk and Reinsurance (IRR), and Benefits Delivery and Administration (BDA).",1.0,0.16242796445858962,1.0
What are the key assumptions used in the valuation of Willis Towers Watson's defined benefit pension plans?,"The key assumptions used in the valuation of Willis Towers Watson's defined benefit pension plans typically include:

1. **Discount Rate**: The interest rate used to discount future pension obligations to their present value. This is often based on high-quality corporate bond yields or government bond rates.
2. **Expected Rate of Return on Plan Assets**: The long-term rate of return expected on the assets held by the pension plan.
3. **Salary Growth Rate**: The assumed annual increase in employee compensation, which affects the calculation of future benefit payments.
4. **Mortality Rates**: Assumptions about the life expectancy of plan participants, which impact the duration of benefit payments.
5. **Turnover and Retirement Rates**: Assumptions about the likelihood of employees leaving the company or retiring, affecting the number of future benefit payments.
6. **Healthcare Cost Trend Rates**: For plans including health benefits, assumptions about the rate at which healthcare costs are expected to increase.

These assumptions are critical for determining the present value of pension liabilities and the associated expense on the financial statements. The specific values used can vary based on the plan's design, geographic location, and actuarial guidelines.","The key assumptions include discount rates, expected long-term rates of return on plan assets, rates of participant mortality, expected long-term rates of compensation and pension increases.",5.0,0.6137637316971628,1.0
How does Willis Towers Watson recognize revenue from broking services?,"Willis Towers Watson recognizes revenue from broking services over time as the services are performed, typically based on the satisfaction of performance obligations in accordance with the revenue recognition principle under IFRS 15 or ASC 606. Revenue is recognized in the period when the insurance or risk management services are provided, which often aligns with the delivery of the service or the passage of time for ongoing services, such as brokerage and advisory work. The exact timing and method depend on the nature of the arrangement, including whether services are delivered over time or at a point in time, and the contract terms.","Revenue from broking services is recognized at the later of the policy inception date or when the policy placement is complete, as this is viewed as the date when control is transferred to the client.",3.0,0.6236151837922982,1.0
What are the key risks and uncertainties related to the COVID-19 pandemic that Willis Towers Watson has considered in its financial statements?,I don't know.,"The key risks and uncertainties include the collectability of billed and unbilled receivables, the estimation of revenue, and the fair value of reporting units, tangible and intangible assets, and contingent consideration.",1.0,0.22858130677538865,0.0
"What is the total amount of remaining performance obligations as of December 31, 2020, and how is it expected to be recognized in future periods?",I don't know.,"As of December 31, 2020, approximately $8.4 billion of total revenues, including deferred installation revenues, are expected to be recognized in future periods, the majority of which will be recognized over the next 24 months.",1.0,0.23232943319475463,0.0
"How did the adoption of Topic 842 (Leases) impact the Company's financial results on January 1, 2019?",I don't know.,"On January 1, 2019, the adoption of Topic 842 resulted in the recognition of new ROU assets and liabilities on the balance sheet for all operating leases, and the de-recognition of existing build-to-suit assets and liabilities with a cumulative effect adjustment to retained earnings.",1.0,0.2284258803423488,0.0
"What are the key risks and uncertainties that may have a material adverse effect on the company's business, financial condition, or results of operations?",I don't know.,"The key risks include uncertainty regarding future revenue and access to funding, potential failure to develop or commercialize drug or biologic product candidates, clinical trial delays, reliance on third parties for management of clinical programs and manufacturing, extensive regulation by government and regulatory agencies, and reliance on intellectual property.",1.0,0.26043908913562025,0.0
How does the company plan to address the risk of failing to obtain regulatory approval for its product candidates?,I don't know.,"The company plans to navigate the regulatory approval process by ensuring compliance with all necessary clinical trial designs, data submissions, and regulatory requirements. It also aims to maintain open communication with regulatory authorities to address any issues promptly.",1.0,0.27510874432195587,0.5
What are the potential impacts of clinical trial delays on the company's business?,"Clinical trial delays can have several significant impacts on a company's business, including:

1. **Increased Costs**: Delays extend the duration of the trial, leading to higher expenses related to personnel, research, regulatory compliance, and monitoring.

2. **Delayed Revenue**: A delayed trial means a later submission for regulatory approval and, consequently, a later market launch, postponing potential revenue generation.

3. **Loss of Competitive Advantage**: Competitors may launch similar products first, capturing market share and establishing brand loyalty.

4. **Investor Confidence**: Prolonged delays can lead to decreased investor confidence, potentially affecting stock prices and the company’s ability to raise capital.

5. **Regulatory and Legal Risks**: Delays may raise concerns with regulatory agencies, potentially leading to increased scrutiny or requests for additional data.

6. **Reputational Damage**: Public perception of the company's efficiency and reliability may suffer, affecting partnerships and stakeholder trust.

7. **Impact on Drug Development Pipeline**: Delays in one trial can cascade through the development pipeline, affecting the timing and prioritization of other projects.

These factors collectively can reduce the company's overall profitability and strategic flexibility.","Clinical trial delays could result in increased costs, delays in advancing product candidates, and potential loss of market opportunities, which could harm the company's competitive position and financial performance.",5.0,0.7577234935712638,1.0
How does the company plan to manage the financial risk associated with the need for substantial additional funding?,I don't know.,"The company plans to manage this risk through a combination of public or private equity offerings, debt financings, collaborations, strategic alliances, licensing arrangements, and other marketing or distribution arrangements to secure the necessary capital on acceptable terms.",1.0,0.19540397390006453,0.5
What are the potential consequences of material weaknesses in the company's internal control over financial reporting?,"The potential consequences of material weaknesses in a company's internal control over financial reporting include:

1. **Inaccurate Financial Reporting**: Increased risk of material misstatements in financial statements due to ineffective controls.
2. **Loss of Investor Confidence**: Investors may lose trust in the company’s financial integrity, leading to a decline in stock price.
3. **Regulatory Scrutiny**: The company may face investigations or penalties from regulatory bodies such as the SEC.
4. **Auditor Qualifications**: Auditors may issue a qualified opinion or disclaim an opinion on the financial statements.
5. **Increased Compliance Costs**: The company may incur higher costs to remediate control deficiencies and improve internal controls.
6. **Operational Disruptions**: Underlying control failures could affect business operations and management efficiency.
7. **Legal Liability**: Potential exposure to lawsuits from shareholders or regulators if financial misstatements cause harm.
8. **Reduced Access to Capital**: Lenders and investors may be less willing to provide financing due to perceived risk.

These consequences can significantly impact the company’s financial health, reputation, and long-term sustainability.","Material weaknesses could lead to a failure to maintain compliance with securities law requirements, loss of investor confidence, and a decline in the company's share price. It could also result in investigations by regulatory authorities.",5.0,0.6893627462248915,1.0
"What was the total purchase price for the acquisition of eNett and Optal by WEX Inc., and how was this amount allocated?",I don't know.,"The total purchase price for the acquisition of eNett and Optal by WEX Inc. was $577.5 million. This amount was allocated to the acquired businesses based on their estimated fair value of $415 million, with the residual value of $162.5 million allocated to the legal settlement.",1.0,0.21526377052471263,0.5
What measures did WEX Inc. take in response to the COVID-19 pandemic to safeguard its business and employees?,I don't know.,"WEX Inc. took several precautionary measures in response to the COVID-19 pandemic, including restricting business travel, temporarily closing offices, canceling participation in industry events, permanently reducing headcount, and furloughing employees across worldwide offices where necessary.",1.0,0.3119580507907333,0.0
What is the primary focus of the company's business?,I don't know.,The company is a clinical-stage biopharmaceutical company dedicated to developing next-generation immunotherapies to transform the lives of patients with cancer by offering better and more durable benefits than currently available immuno-oncology treatments.,1.0,0.26451930773446125,0.5
What are the main product candidates currently under development by the company?,I don't know.,"The main product candidates are FS118, a tetravalent mAb2 bispecific antibody targeting PD-L1 and LAG-3; FS120, a dual agonist bispecific antibody stimulating CD137 and OX40; FS222, a bispecific antibody targeting CD137 and PD-L1; and SB 11285, a next-generation cyclic dinucleotide-based STING agonist.",1.0,0.18424177321814184,0.5
What are the key challenges and competitive landscape for the company's immuno-oncology therapies?,I don't know.,"The company faces potential competition from many sources, including large biotechnology and pharmaceutical companies, academic institutions, government agencies, and other public and private research organizations. The immuno-oncology field is characterized by rapidly advancing technologies and innovation, intense competition, and a strong emphasis on intellectual property.",1.0,0.24186570683194283,0.0
What are the regulatory requirements for marketing approval of the company's product candidates in the United States?,I don't know.,"The regulatory requirements include completing nonclinical laboratory tests and animal studies, submitting an Investigational New Drug (IND) application, conducting adequate and well-controlled human clinical trials, submitting a Biologics License Application (BLA) or New Drug Application (NDA), undergoing FDA pre-approval inspections of manufacturing facilities, and potential FDA audits of clinical trial sites.",1.0,0.27258370089533135,0.0
What are the potential environmental risks associated with the Partnership’s operations?,I don't know.,"The Partnership’s operations involve the generation, handling, and disposal of hazardous substances, hydrocarbons, and wastes, which are subject to stringent environmental laws and regulations. Non-compliance with these laws could result in significant penalties, remediation costs, and other liabilities.",1.0,0.22419056172626306,0.0
How does the Partnership’s reliance on key customers impact its financial results?,I don't know.,The Partnership’s intrastate and interstate transportation and storage operations depend on key customers to transport natural gas through its pipelines. The failure of these major shippers to fulfill their contractual obligations could have a material adverse effect on the Partnership’s cash flow and results of operations.,1.0,0.22805307993741414,0.0
What are the major types of revenue within the Partnership's reportable segments?,I don't know.,"The major types of revenue within the Partnership's reportable segments include intrastate transportation and storage, interstate transportation and storage, midstream, NGL and refined products transportation and services, crude oil transportation and services, investment in Sunoco LP, investment in USAC, and all other.",1.0,0.14227075146934876,0.0
"What is the total amount of long-term debt as of December 31, 2020?",I don't know.,"The total amount of long-term debt as of December 31, 2020 was $51.37 billion.",1.0,0.2705234166835569,0.5
How does the Partnership determine the fair value of its financial assets and liabilities?,"The Partnership determines the fair value of its financial assets and liabilities based on the fair value hierarchy established by accounting standards, which prioritizes the use of observable inputs. Fair value is measured as the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. The Partnership considers the following levels in order of priority:

1. **Level 1**: Quoted prices in active markets for identical assets or liabilities.
2. **Level 2**: Inputs other than quoted prices included in Level 1 that are observable for the asset or liability, such as quoted prices for similar assets or liabilities in active markets, or other observable inputs.
3. **Level 3**: Unobservable inputs reflecting the Partnership's own assumptions about the assumptions that market participants would use in pricing the asset or liability.

The Partnership uses valuation techniques appropriate to the nature of the asset or liability, such as discounted cash flow models, market multiples, or option pricing models, depending on the availability and reliability of observable inputs. The determination of fair value is based on the exit price concept, meaning the price at which an asset could be sold or a liability transferred in an orderly transaction between market participants at the measurement date.","The Partnership determines the fair value of its financial assets and liabilities by using the highest possible “level” of inputs, including observable quotes in an active market for identical assets and liabilities (Level 1), inputs observable for similar assets and liabilities (Level 2), and unobservable inputs (Level 3).",5.0,0.844253341511286,1.0
What are the key risks related to the company's financial position as outlined in the financial report?,I don't know.,"The key risks related to the company's financial position include a history of losses, reliance on a limited number of significant clients, and the need for additional capital to support business growth.",1.0,0.22851809078538243,0.0
How does the company's dependence on a few large clients impact its financial stability?,"The company's dependence on a few large clients can increase its financial instability because losing even one major client could significantly reduce revenue. This concentration of business exposes the company to higher risk, as it may struggle to maintain profitability or cover fixed costs if those clients reduce orders, negotiate lower prices, or leave. Additionally, such reliance can limit the company's bargaining power and hinder its ability to diversify or grow sustainably.","The company's dependence on a few large clients, such as Anthem, exposes it to significant financial risk if any of these clients were to reduce their business or terminate their contracts, which could materially affect revenue and financial stability.",5.0,0.8139993074821502,1.0
What are the potential impacts of rapid technological changes on the company's business?,"Rapid technological changes can impact a company's business in several ways, including:

1. **Increased Competition**: New technologies can lower barriers to entry, allowing new competitors to emerge and challenge existing market leaders.

2. **Operational Efficiency**: Automation and advanced software can improve productivity, reduce costs, and streamline processes.

3. **Product and Service Innovation**: Companies can develop new products or enhance existing ones to meet evolving customer needs more effectively.

4. **Customer Expectations**: Faster innovation can raise customer expectations for speed, convenience, and personalization.

5. **Skill Gaps**: Rapid technological change may require employees to acquire new skills, potentially leading to workforce restructuring or training needs.

6. **Disruption of Business Models**: Established industries may be disrupted by new technologies, making current business models obsolete.

7. **Cybersecurity Risks**: As companies adopt new technologies, they may become more vulnerable to cyber threats.

8. **Investment Pressures**: Continuous technological advancement may require significant investment in R&D, infrastructure, or acquisitions.

9. **Market Shifts**: New technologies can create or reshape markets, altering the company’s strategic positioning.

10. **Regulatory Challenges**: Fast-changing technologies may outpace existing regulations, leading to compliance risks or uncertainty.

Companies must adapt quickly to leverage opportunities and mitigate risks associated with rapid technological change.","Rapid technological changes pose a risk of obsolescence for the company's current technology and services, requiring continuous investment in research and development to stay competitive and relevant in the market.",5.0,0.595741644747069,1.0
What is the primary risk factor mentioned in the financial report regarding the legality of cannabis under U.S. federal law?,"The primary risk factor mentioned in the financial report regarding the legality of cannabis under U.S. federal law is that cannabis remains classified as a Schedule I controlled substance under the Controlled Substances Act, which creates legal and regulatory uncertainty, limits access to banking and financial services, and poses compliance challenges for businesses operating in the cannabis industry.","The primary risk factor is that cannabis remains illegal under U.S. federal law, which could lead to enforcement actions by federal authorities and potentially harm the company's business operations and financial condition.",5.0,0.8450149203673553,1.0
What are the potential consequences if the company fails to comply with state regulations in the jurisdictions where it operates?,"The potential consequences of failing to comply with state regulations can include fines, penalties, legal action, loss of business licenses, damage to the company's reputation, and in severe cases, suspension or termination of operations in that jurisdiction.","If the company fails to comply with state regulations, it could face sanctions including revocation or additional conditions on licenses, suspension or expulsion from markets, imposition of fines and censures, and potential material liabilities or revocation of licenses and permits.",5.0,0.8499271298095713,1.0
What measures does the company take to mitigate the risk of security breaches and theft in its operations?,I don't know.,"The company has implemented security measures at its facilities and engages a security firm for the transport and movement of large amounts of cash and products, including escorting employees by armed guards when necessary.",1.0,0.2684875292208426,0.0
What are the potential impacts of a global economic slowdown or financial market disruptions on the company's business?,I don't know.,"A global economic slowdown or financial market disruptions could lead to decreased consumer spending, reduced demand for the company's products, increased competition, and potentially lower revenues and profitability.",1.0,0.2920722720371023,0.0
"What critical audit matter was identified in the audit of Evergy, Inc.'s financial statements?",I don't know.,"The critical audit matter identified was the impact of rate regulation on the financial statements, particularly related to the accounting for the economics of rate regulation which impacts multiple financial statement line items and disclosures. This matter involved especially challenging, subjective, or complex judgments due to the high degree of subjectivity involved in assessing the impact of future regulatory orders on the financial statements.",1.0,0.2628536673400186,0.0
"What are the key components of Evergy, Inc.'s property, plant, and equipment accounting?",I don't know.,"The key components of Evergy, Inc.'s property, plant, and equipment accounting include recording the value at cost, which includes contracted services, direct labor and materials, indirect charges for engineering and supervision, and an allowance for funds used during construction (AFUDC). Depreciation and amortization are computed using the straight-line method over the estimated lives of depreciable property based on rates approved by state regulatory authorities.",1.0,0.21703939121126098,0.0
"How does Evergy, Inc. account for nuclear plant decommissioning costs?","Evergy, Inc. accounts for nuclear plant decommissioning costs by recognizing the estimated costs over the operational life of the nuclear plants through a decommissioning trust fund. These costs are funded through ratepayer contributions and are included in the utility's regulatory assets, allowing recovery through customer rates. The company follows accounting standards such as ASC 460 (Obligations Resulting from Decommissioning) and regulatory guidance to reflect the liabilities and funding obligations associated with decommissioning.","Evergy, Inc. accounts for nuclear plant decommissioning costs by contributing to a tax-qualified trust fund to be used to decommission Wolf Creek. Related liabilities for decommissioning are included in asset retirement obligations (AROs) on the consolidated balance sheets. Differences between the decommissioning trust fund asset and the related ARO are recorded as a regulatory asset or liability, reflecting the authorized regulatory treatment and related regulatory accounting.",4.0,0.8043993696561591,1.0
How does reliance on third-party manufacturers impact our business?,"Reliance on third-party manufacturers can impact your business in several ways:

1. **Cost Efficiency**: Outsourcing manufacturing can reduce overhead costs, as third-party manufacturers handle production, labor, and equipment expenses.

2. **Scalability**: It allows for quicker scaling of production to meet demand without significant capital investment in facilities or machinery.

3. **Quality Control**: Dependence on external producers may lead to variability in product quality, especially if oversight is limited or standards are not consistently enforced.

4. **Supply Chain Risks**: Disruptions in the third-party manufacturer’s operations—such as natural disasters, labor strikes, or logistics issues—can delay production and impact delivery.

5. **Intellectual Property Concerns**: Sharing product designs or proprietary processes with third parties may pose risks of imitation or unauthorized use.

6. **Loss of Control**: You may have less control over production timelines, innovation cycles, and responsiveness to customer feedback.

7. **Sustainability and Ethical Compliance**: Ensuring that third-party manufacturers adhere to environmental and labor standards can be challenging and require regular audits.

8. **Long-Term Relationships**: Building strong, reliable partnerships with manufacturers can enhance efficiency and innovation, but poor relationships may lead to inefficiencies or increased costs.

Overall, the impact depends on the manufacturer’s reliability, alignment with your business goals, and the strength of your management and oversight systems.","Reliance on third-party manufacturers increases the risk of supply disruptions, quality control issues, and potential delays in product development and commercialization, which could adversely affect our ability to generate revenue.",4.5,0.7387832821388759,1.0
"How does KemPharm, Inc. recognize revenue from contracts with customers?",I don't know.,"KemPharm recognizes revenue in accordance with ASC 606, which involves identifying performance obligations, determining the transaction price, allocating the transaction price to each performance obligation, and recognizing revenue when (or as) each performance obligation is satisfied.",1.0,0.24587727173146728,0.0
"How has KemPharm, Inc. addressed its liquidity concerns?",I don't know.,"After taking into account the underwritten public offering, debt restructuring with subsequent payoff, and warrant inducement transactions discussed in Note R, the Company's cash and cash equivalents as of the filing date are sufficient to fund the Company's operating expenses and capital expenditure requirements for at least one year from the date the financial statements are issued.",1.0,0.18754158878657562,0.5
What are the terms of the KP415 License Agreement with Commave Therapeutics SA?,I don't know.,"Under the KP415 License Agreement, KemPharm granted Commave an exclusive, worldwide license to develop, manufacture, and commercialize the Company’s product candidates containing serdexmethylphenidate (SDX) and d-methylphenidate (d-MPH), including AZSTARYS, KP484, and optionally KP879, KP922, or any other product candidate developed by the Company containing SDX and developed to treat ADHD or any other central nervous system disorder. Commave paid an upfront payment of $10.0 million and agreed to pay milestone payments, sales milestones, and tiered royalty payments on net sales.",1.0,0.20621169369767925,1.0
What was the outcome of the debt restructuring mentioned in the financial report?,I don't know.,"In anticipation of the Public Offering, the Company restructured the December 2019 Notes and the January 2020 Note in the aggregate principal amount of $60.8 million and the Deerfield Note in the principal amount of $7.5 million. The Company exchanged $31.5 million of the outstanding principal and accrued interest on the Facility Notes for Series B-2 Preferred Stock and Exchange Warrants and made a payment of $30.3 million in partial repayment of the remaining outstanding principal and accrued interest on the Facility Notes.",1.0,0.1858588449900907,0.5
What is the role of the Dividend Retention Fund in Chubb's operations?,I don't know.,"The Dividend Retention Fund is used to maintain the statutory capital and surplus of Century Indemnity Company, a subsidiary of Chubb, by replenishing the principal to $50 million from dividends withheld from Chubb Group Holdings.",1.0,0.25848419380522336,0.0
How does Chubb manage its foreign currency exposure?,"Chubb manages its foreign currency exposure through a combination of natural hedging, hedging instruments, and financial risk management strategies. The company utilizes derivative financial instruments, such as forward contracts and options, to hedge against fluctuations in foreign exchange rates that could impact its cash flows and earnings. Additionally, Chubb employs operational strategies, such as aligning revenues and expenses in the same currency, to reduce exposure. The company regularly reviews its foreign currency exposure and adjusts its hedging strategies as needed to mitigate risk while optimizing financial performance.","Chubb manages its foreign currency exposure by using foreign currency forward contracts to exchange specific currencies at a future date, aiming to minimize the effect of fluctuating foreign currencies.",4.5,0.8332213578249024,1.0
What is the impact of the COVID-19 pandemic on Chubb's unpaid losses and loss expenses in 2020?,I don't know.,"The COVID-19 pandemic led to an increase in Chubb's unpaid losses and loss expenses in 2020, primarily due to catastrophe losses incurred.",1.0,0.30083303761593266,0.0
What is the policy for dividend distributions from Chubb Limited?,"Chubb Limited has a dividend policy that emphasizes returning capital to shareholders through regular and sustainable dividend payments. The company generally aims to pay dividends on a regular basis, with the amount and timing subject to approval by the Board of Directors. Chubb targets a long-term dividend payout ratio of approximately 40% of its annual net income, which is consistent with the company's focus on maintaining a strong balance sheet and supporting long-term shareholder value. Dividend decisions are influenced by factors such as financial performance, capital adequacy, regulatory requirements, and overall business strategy. For the most current and detailed information, shareholders should refer to Chubb's official investor relations website or recent financial reports.","Chubb Limited issues dividends without subjecting them to withholding tax by way of distributions from capital contribution reserves and payment out of free reserves, with dividends stated in Swiss francs but paid in U.S. dollars.",3.0,0.6232623294345083,1.0
What are the principal risk factors associated with investing in the company's securities?,I don't know.,"Investing in the company's securities involves a high degree of risk, including speculative and leveraged investments, potential loss of capital, regulatory restrictions, and exposure to market volatility.",1.0,0.34193984994956245,0.0
How does the company's business model depend on referral relationships with venture capital and private equity fund sponsors?,I don't know.,The company's business model significantly relies on strong referral relationships with venture capital and private equity fund sponsors to generate investment opportunities. The inability to maintain or develop these relationships could adversely affect the company's business.,1.0,0.25178746745434555,0.0
What are the regulatory risks the company faces as a Business Development Company (BDC)?,"A Business Development Company (BDC) faces several regulatory risks due to its structure and the requirements imposed by the Investment Company Act of 1940 and the Internal Revenue Code. These include:

1. **Compliance with the 1940 Act**: BDCs must adhere to specific provisions under the Investment Company Act, such as restrictions on leverage, asset diversification requirements, and limitations on transactions with affiliates. Failure to comply may result in enforcement actions or loss of BDC status.

2. **Maintaining Qualifying Income**: BDCs must derive at least 70% of their gross income from dividends, interest, and other income related to their investment in portfolio companies. Non-compliance could jeopardize their tax status.

3. **Asset Composition Requirements**: At least 70% of the BDC’s total assets must be qualifying assets, which include investments in private or thinly traded companies. Failure to meet this requirement may result in a loss of BDC status.

4. **Leverage Limitations**: While BDCs can use debt to finance investments, they are subject to limitations on the amount of leverage they can use, and must maintain a ratio of net asset value to total debt. Exceeding these limits may lead to regulatory scrutiny.

5. **Governance and Disclosure Requirements**: BDCs are required to have independent board members and must provide detailed disclosures about their investment activities, risk exposures, and performance. Failure to meet these governance and transparency standards can lead to regulatory penalties.

6. **Tax Compliance Risks**: BDCs must maintain compliance with IRS rules to preserve their pass-through tax status. Missteps in tax reporting or structure could result in adverse tax consequences.

7. **SEC Oversight and Enforcement**: The SEC closely monitors BDCs, and non-compliance with regulations or securities laws can lead to fines, enforcement actions, or restrictions on operations.

Failure to address these regulatory risks can result in loss of BDC status, increased costs, or damage to investor confidence.","As a BDC, the company is subject to regulatory constraints that may affect its ability to raise additional capital, incur debt, and make certain investments. Non-compliance with BDC regulations could lead to loss of status or enforcement actions.",5.0,0.7516748527669811,1.0
How does the company's exposure to changes in interest rates affect its profitability?,I don't know.,"Changes in interest rates can impact the company's net investment income, as higher rates may increase borrowing costs and reduce the demand for loans, while lower rates may decrease yields on new investments.",1.0,0.2903481757909803,0.0
What is the nature of the Company's business and what types of companies does it primarily lend to?,I don't know.,"The Company is a specialty finance company focused on providing senior secured loans to high-growth, innovative venture capital-backed companies in various technology, life sciences, and sustainable and renewable technology industries.",1.0,0.2387848421720253,0.0
"What is the Company's policy regarding the declaration and payment of dividends, and how does it affect its tax status?",I don't know.,"The Company's policy is to declare and pay dividends on a quarterly basis, ensuring that it distributes at least 90% of its investment company taxable income to maintain its RIC tax status. This avoids federal income tax on the distributed portion of its taxable income.",1.0,0.18232017120229663,0.0
"How does the Company manage its credit risk, and what measures are in place to mitigate potential losses?",I don't know.,"The Company manages its credit risk through rigorous credit assessment processes, including obtaining first priority security interests in portfolio companies' assets, which may include intellectual property. It also monitors portfolio companies' financial performance and market conditions to mitigate potential losses.",1.0,0.18065771454554527,0.0
What was the impact of the adoption of ASC 606 on the company's revenue recognition?,I don't know.,The adoption of ASC 606 accelerated the timing of recognition of a portion of original listing fees related to the New York Stock Exchange businesses and decelerated the timing of recognition of a portion of clearing fee revenues.,1.0,0.22061610638532678,0.0
How does the company account for stock-based compensation?,I don't know.,"The company measures and recognizes compensation expense for share-based payment awards, including employee stock options, restricted stock, and shares purchased under the Employee Stock Purchase Plan, based on estimated fair values on the date of grant. The value of the portion of the award that is ultimately expected to vest is recognized as stock-based compensation expense over the requisite service period.",1.0,0.24987210166376028,0.0
What is the primary function of the Exchanges segment?,"The primary function of the Exchanges segment is to facilitate the trading of financial instruments such as stocks, bonds, derivatives, and commodities by providing a structured and regulated marketplace where buyers and sellers can transact efficiently.","The Exchanges segment operates regulated marketplaces for the listing, trading, and clearing of a broad array of derivatives contracts and financial securities.",5.0,0.8112854632436877,1.0
What services does the Fixed Income and Data Services segment provide?,"The Fixed Income and Data Services segment provides services related to fixed income securities, including trading, research, and analytics, as well as data products and solutions that support investment decision-making, risk management, and compliance for institutional investors. These services typically include pricing data, credit analysis, yield curve modeling, and portfolio management tools.","This segment provides fixed income pricing, reference data, indices, execution services, global credit default swaps clearing, and multi-asset class data delivery solutions.",4.0,0.7633469999193462,1.0
What is the significance of the NYSE in the company's Exchanges segment?,"The NYSE (New York Stock Exchange) is a key component of the company's Exchanges segment, representing one of the largest and most influential stock exchanges globally. It plays a significant role in facilitating the trading of equities, derivatives, and other financial instruments, contributing substantially to the company's revenue and market presence. Its reputation, liquidity, and regulatory oversight enhance the company's credibility and operational scale within the financial markets.","The NYSE is the global leader in listings, having been the venue of choice for innovators, visionaries, and leaders for over 225 years, and it is the leading listing venue across a range of sectors.",4.5,0.7060434540863032,1.0
What measures have been taken to protect the company from clearing member defaults?,"To protect the company from clearing member defaults, measures typically include:  

1. **Margin Requirements**: Requiring clearing members to deposit initial and variation margins to cover potential losses.  
2. **Segregation of Client Assets**: Keeping client funds and securities separate from the clearing member's own assets.  
3. **Default Management Procedures**: Establishing protocols to handle member defaults, including close-out of positions and use of default funds.  
4. **Default Funds**: Maintaining a collective default fund contributed by clearing members to absorb losses in the event of a default.  
5. **Risk Monitoring and Stress Testing**: Continuously assessing members’ risk exposure and conducting stress tests to evaluate resilience under adverse scenarios.  
6. **Collateral Haircuts**: Applying haircuts to collateral to account for market volatility and liquidity risks.  
7. **Early Warning Systems**: Using monitoring tools to detect signs of financial distress in members.  
8. **Regulatory Oversight**: Complying with regulations set by authorities to ensure robust risk controls.  

These measures collectively reduce the risk of losses and maintain the integrity of the clearing system.",The company has contributed its own cash to the guaranty funds and added a layer of insurance to its clearing member default protection.,3.0,0.6179633730323012,1.0
How does the company's data services offerings aim to address market demands?,I don't know.,"The company's data services offerings aim to address the rising demand for independent, real-time information, which is being driven by regulation, market fragmentation, increasing technology and data demands, and passive investing and indexation.",1.0,0.19054723038425592,0.0
How does the company manage cybersecurity risks?,I don't know.,"The company employs a Cybersecurity Strategy (CSS) that emphasizes ongoing intelligence collection regarding cybersecurity threats and initiatives to address prominent areas of cybersecurity risk, including the deployment of external and internal teams of ethical hackers.",1.0,0.22992661549252588,0.0
How does the fair value determination of our portfolio investments impact our financial condition?,"The fair value determination of portfolio investments impacts our financial condition by influencing the reported value of assets on our balance sheet, which in turn affects key financial ratios, equity levels, and potentially earnings. Changes in fair value, particularly for investments measured at fair value through profit or loss (FVTPL) or fair value through other comprehensive income (FVOCI), are recognized in the income statement or other comprehensive income, respectively, thereby impacting net income and retained earnings. This can affect liquidity, solvency, and investor perceptions of the company’s financial health.","The fair value determination of our portfolio investments is subjective and dependent on a valuation process approved by our Board. Fair value fluctuations may cause our net asset value to materially understate or overstate the value we may ultimately realize on our investments, impacting our financial condition.",4.5,0.6273255094472193,1.0
How does the highly competitive market for investment opportunities affect our business?,"The highly competitive market for investment opportunities can impact our business by increasing pressure to offer attractive returns, improving operational efficiency, and requiring innovation to stand out. It may also lead to higher costs for capital and increased competition for talent. However, it can drive better decision-making and attract more strategic partners and investors.","The highly competitive market for investment opportunities could reduce returns and result in losses as we may lose investment opportunities to competitors with greater financial, technical, and marketing resources. Competitors may also offer better pricing and more flexible structuring, forcing us to match their terms or forego opportunities.",4.0,0.7863468708182276,1.0
What measures are in place to manage the risk of material non-public information limiting our investment discretion in portfolio companies?,"To manage the risk of material non-public information (MNPI) limiting investment discretion in portfolio companies, firms typically implement a comprehensive set of measures, including:

1. **Chinese Wall (Information Barrier) Policies**: Establishing strict separation between teams involved in investment decisions and those with access to MNPI, such as analysts or portfolio managers.

2. **Access Controls**: Limiting access to sensitive information on a need-to-know basis, ensuring only authorized personnel can view or use material non-public data.

3. **Conflicts of Interest Policies**: Prohibiting or monitoring trading and investment decisions by employees who may have access to MNPI, including blackout periods or mandatory cooling-off periods.

4. **Compliance and Training Programs**: Regular training for employees on compliance with insider trading laws and internal policies.

5. **Monitoring and Auditing**: Ongoing monitoring of communications, trades, and access logs to detect potential breaches.

6. **Legal and Regulatory Compliance**: Adhering to regulations such as the Securities Exchange Act of 1934, Rule 10b-5, and SEC guidelines regarding the use of MNPI.

7. **Formal Policies and Procedures**: Documented policies that govern handling of MNPI, including disclosure protocols and reporting requirements.

These measures are designed to prevent misuse of MNPI and to preserve investment discretion while complying with legal and ethical standards.","Members of our Investment Advisor’s investment committee and other investment professionals may serve as directors or in similar capacities in portfolio companies. If material non-public information is obtained, we could be prohibited from purchasing or selling securities of such companies, limiting our investment discretion.",4.5,0.5888883434168372,1.0
How does the involvement of interested directors in the valuation process create potential conflicts of interest?,"The involvement of interested directors in the valuation process can create potential conflicts of interest because these directors may have personal, financial, or other interests that could influence their judgment. For example, if a director holds significant shares in the company or has a financial stake in a particular outcome, they might be inclined to bias the valuation in a way that benefits their personal interests rather than the best interests of the company or its shareholders. This can compromise the objectivity and fairness of the valuation, undermining the integrity of the decision-making process.","The involvement of interested directors in the valuation process could result in conflicts of interest as the Investment Advisor’s management fee is based on the value of our gross assets, and its incentive fees are based on realized and unrealized gains. This participation could influence the valuation process in a way that may not be in the best interest of all stockholders.",4.0,0.7524891638216327,1.0
What are the implications of the terms of the Investment Advisory Agreement and the Administration Agreement not being negotiated on an arm’s length basis?,"If the terms of the Investment Advisory Agreement and the Administration Agreement are not negotiated on an arm’s length basis, it may imply that the agreements are not at fair market value or are favoring one party over another. This could raise concerns about conflicts of interest, potential misappropriation of fund assets, or improper compensation to the advisor or administrator. Such arrangements may violate regulatory requirements, particularly under securities laws and fund governance rules, which require that transactions between a fund and its service providers be conducted on terms no less favorable than those available from unaffiliated parties. This could lead to regulatory scrutiny, enforcement actions, or the need to renegotiate or amend the agreements to ensure compliance.","The non-arm’s length negotiation of these agreements may result in terms that are not as favorable to us as if they had been negotiated with an unaffiliated third-party. This could include higher fees and less favorable incentive fee structures, which may induce the Investment Advisor to pursue speculative investments or use leverage when it may not be advisable.",4.0,0.7116922499578199,1.0
How does the potential for PIK interest payments affect our assets under management and the fees payable to Capitala Investment Advisors?,I don't know.,"PIK interest payments increase the size of the loan balance, thereby increasing our assets under management. This results in an increase in the base management fee payable to the Investment Advisor. Additionally, the accrual of interest on the higher loan balance increases our pre-incentive fee net investment income, leading to an increase in incentive fees.",1.0,0.2233078811720378,0.0
What are the primary risks associated with the commercial success of our products in the U.S.?,I don't know.,"The primary risks include the inability to meet sales expectations, attain profitability and positive cash-flow from operations, and the dependency on the effectiveness of sales, managed markets, marketing efforts, and support for our products.",1.0,0.2455409730641148,0.0
What are the potential consequences of failing to comply with cGMP regulations in our manufacturing processes?,"Failing to comply with cGMP (Current Good Manufacturing Practice) regulations can lead to several serious consequences, including:

1. **Regulatory Actions**: Regulatory agencies such as the FDA may issue warning letters, impose fines, or initiate legal proceedings.
2. **Product Recalls**: Non-compliant products may be recalled, leading to financial loss and damage to reputation.
3. **Manufacturing Shutdowns**: Authorities may suspend or shut down production until compliance is achieved.
4. **Loss of Market Authorization**: Companies may lose approval to market their products.
5. **Financial Penalties**: Fines and legal costs can be substantial.
6. **Reputational Damage**: Loss of trust from customers, regulators, and investors can impact long-term business sustainability.
7. **Product Quality Risks**: Non-compliance can result in contaminated, ineffective, or unsafe products, potentially harming consumers.

Compliance with cGMP is essential to ensure product safety, efficacy, and quality.","Failure to comply with cGMP regulations could result in product seizures, recalls, or withdrawals, suspension or withdrawal of marketing approvals, fines, and criminal prosecutions, which could significantly harm our business.",5.0,0.8725734007073656,1.0
What are the key provisions in our loan agreement that could restrict our operations?,I don't know.,"The loan agreement contains negative covenants that restrict our ability to sell or dispose of assets, amend certain material agreements, consolidate or merge, incur additional indebtedness, incur additional liens, pay dividends or make certain payments, and make payments of certain subordinated indebtedness.",1.0,0.2746722246293401,0.0
How does the classification of our board of directors into two classes affect our corporate governance?,"The classification of a board of directors into two classes affects corporate governance by stabilizing board leadership and reducing the likelihood of a hostile takeover. By staggering board terms, only a portion of directors is up for election each year, which can prevent a single shareholder or group from gaining control of the board through a proxy fight. This structure encourages continuity and long-term strategic planning, but may also reduce board accountability and agility in responding to changes in company performance or external threats.","The classification of our board of directors into two classes, with one class elected each year, may make it more difficult for a third party to acquire control of us or effect a change in our board of directors and management, potentially deterring hostile takeovers or changes in control.",4.5,0.7401942972623439,1.0
What are the potential impacts of Brexit on our international operations?,I don't know.,"Brexit could lead to legal uncertainty and divergent national laws and regulations, new regulatory costs and challenges, potential restrictions on direct investments by foreign entities and trade restrictions, and changes in tax laws and tariffs, which could adversely affect our operations.",1.0,0.2608503506378741,0.0
How does the company plan to manage the transition from a research and development focus to commercial activities?,I don't know.,"The company may encounter unforeseen expenses, difficulties, complications, delays, and other known and unknown obstacles during this transition. It may not be successful in this transition, which could adversely affect its business.",1.0,0.35223164388590816,0.5
What are the potential consequences if the company is unable to raise additional funding when needed?,"If a company is unable to raise additional funding when needed, it may face several potential consequences, including:

1. **Cash Flow Problems**: The company may struggle to meet short-term obligations such as paying employees, suppliers, or rent.
2. **Operational Halt**: Critical operations may be disrupted or shut down due to lack of resources.
3. **Loss of Competitive Advantage**: Inability to invest in innovation, marketing, or expansion could lead to a decline in market share.
4. **Reduced Investor Confidence**: Existing and potential investors may lose confidence, making future fundraising even harder.
5. **Bankruptcy or Liquidation**: In severe cases, the company may be forced into bankruptcy or be compelled to sell assets to settle debts.
6. **Talent Attrition**: Key employees may leave for more stable companies, further weakening the organization.
7. **Delayed Growth**: Expansion plans may be put on hold or canceled, limiting long-term growth potential.

These consequences can vary in severity depending on the company's financial health, industry, and the timing of the funding shortfall.","If the company is unable to raise capital when needed, it could be forced to delay, reduce, or eliminate its product development programs or commercialization efforts, which would significantly impact its ability to develop and market its products.",5.0,0.712104173845486,1.0
How does the company's reliance on third-party manufacturers impact its operations?,I don't know.,"The company's reliance on third-party manufacturers for the manufacture of its product candidates and related raw materials may expose it to risks such as unforeseen expenses, difficulties, complications, delays, and other known and unknown obstacles. If these third-party manufacturers fail to comply with regulatory requirements or meet contractual obligations, it could delay or prevent the company's ability to develop or commercialize its product candidates.",1.0,0.23433018048059467,0.0
What are the key risks related to the company's intellectual property?,I don't know.,"The key risks include the inability to obtain, maintain, or adequately protect intellectual property rights, potential infringement claims from third parties, and the uncertainty of patent litigation outcomes. Additionally, the company may face challenges in enforcing its patents and may not be able to prevent competitors from using similar technologies.",1.0,0.2711051687318614,0.0
What is the primary risk associated with investing in the company's common stock?,"The primary risk associated with investing in a company's common stock is the potential for loss of principal and fluctuating returns due to market volatility, company performance, and broader economic factors. Stockholders are last in line to receive assets in the event of liquidation and may receive little or nothing if the company fails. Additionally, dividends are not guaranteed and can be reduced or eliminated at the company's discretion.","Investing in the company's common stock involves a high degree of risk, including the potential for significant losses if the market price of the stock declines.",4.5,0.7429659129194095,1.0
What is the potential impact of the COVID-19 pandemic on the company's business?,I don't know.,"The COVID-19 pandemic has adversely impacted and may continue to adversely impact the company's business, including its preclinical studies and clinical trials, and finances, by causing disruptions in operations, delays in clinical trials, and financial market volatility.",1.0,0.24334831034754045,0.0
What are the risks related to the company's reliance on third-party manufacturers?,"The risks related to a company's reliance on third-party manufacturers include supply chain disruptions, quality control issues, intellectual property theft, dependency on external parties, potential for increased costs, lack of flexibility in production, and reputational damage if the manufacturer engages in unethical practices.","Risks include the potential for not having sufficient quantities of product candidates, failure of third-party manufacturers to comply with regulatory requirements, and the inability to control the quality and timeliness of manufacturing processes.",4.5,0.7780438595933666,1.0
What are the potential consequences of the company's inability to protect its intellectual property rights?,"The potential consequences of a company's inability to protect its intellectual property rights include loss of competitive advantage, reduced revenue due to unauthorized use or imitation of products, damage to brand reputation, increased legal costs, and potential loss of market share. Additionally, it may discourage innovation and investment in research and development.","Inability to protect intellectual property rights could lead to competitors developing and commercializing similar products, which could harm the company's business, financial condition, and competitive position.",5.0,0.7732738468629631,1.0
How does the company's reliance on third-party manufacturers impact its business operations?,I don't know.,"The company's reliance on third-party manufacturers for the production of its product candidates increases the risk of supply chain disruptions, quality control issues, and potential delays in the development and commercialization of its products.",1.0,0.2888484455237789,0.0
How does the company's financial position and need for capital affect its ability to pursue its business objectives?,"A company's financial position and need for capital directly influence its ability to pursue business objectives. A strong financial position, characterized by sufficient cash flow, low debt, and healthy profitability, enables a company to invest in growth opportunities, innovate, and withstand economic downturns. Conversely, a weak financial position or high capital needs may limit investment capacity, increase financial risk, and constrain strategic initiatives. Access to capital—through internal funds or external financing—determines whether a company can expand operations, enter new markets, or respond to competitive pressures. Thus, financial health and capital availability are critical for sustaining and achieving long-term business goals.","The company's need for substantial additional funding to pursue its business objectives may limit its ability to conduct research and development, initiate clinical trials, and seek marketing approval for its product candidates, potentially delaying or preventing the achievement of its goals.",4.0,0.508016924059758,1.0
What are the implications of the company's dual-class stock structure for minority shareholders?,"The implications of a company's dual-class stock structure for minority shareholders include reduced voting power relative to insiders, limited influence over corporate decisions, and potential misalignment of interests between majority and minority shareholders. This structure often allows founders or insiders to maintain control with a smaller percentage of ownership, which can lead to governance concerns and lower accountability to public shareholders.","The dual-class stock structure may limit the ability of minority shareholders to influence corporate matters and could result in decisions that are not aligned with their best interests, as the majority of voting power is concentrated among a few significant stockholders.",5.0,0.8528424982644324,1.0
How does Prelude Therapeutics design its clinical trials?,I don't know.,Prelude Therapeutics designs its clinical trials to leverage the broad utility of its compounds with a focus on efficient regulatory pathways to enable potentially transformative medicines to quickly reach patients with high unmet medical need.,1.0,0.17320550349104824,0.0
How does Prelude Therapeutics protect its intellectual property?,I don't know.,"Prelude Therapeutics protects its intellectual property by seeking and maintaining patent protection for compositions of matter, methods of use, and other inventions important to its business. It also relies on know-how and continuing technological innovation to maintain its proprietary position.",1.0,0.2280887096127279,0.5
What was the primary reason for the decrease in income tax expense in 2020?,I don't know.,"The decrease in income tax expense in 2020 was primarily due to the decrease in total income before tax, which was mainly caused by lower crude oil prices, partially offset by lower impairment and write-off charges.",1.0,0.18043225459534304,0.0
How did Chevron respond to market conditions and the COVID-19 pandemic during 2020?,"In 2020, Chevron responded to market conditions and the COVID-19 pandemic by significantly reducing capital expenditures and operating costs to adapt to the sharp decline in global oil demand and prices. The company suspended its dividend for the first time since 1943, streamlined operations, and focused on maintaining liquidity and financial flexibility. Chevron also implemented workforce reductions and deferred non-essential projects to navigate the economic downturn.","Chevron responded to market conditions and the COVID-19 pandemic by swiftly adjusting controllable items, such as lowering capital expenditures by 35% and reducing operating expenses by $1.4 billion compared to 2019. Additionally, the company suspended its stock repurchase program in March 2020 to protect the dividend and maintain a strong balance sheet.",4.0,0.8932443346909623,1.0
What were the key factors affecting Chevron's upstream segment earnings in 2020?,"In 2020, Chevron's upstream segment earnings were primarily affected by:  
1. **Lower oil and natural gas prices** due to reduced global demand caused by the COVID-19 pandemic.  
2. **Production declines** as a result of reduced drilling and production activities to manage costs.  
3. **Lower realized prices** compared to the previous year, especially in the first half of 2020.  
4. **Cost-cutting measures** and operational efficiencies implemented to mitigate financial impacts.  
5. **Reduced capital expenditures** to preserve cash flow during the downturn.  

These factors collectively led to a significant decline in upstream earnings compared to 2019.","The key factors affecting Chevron's upstream segment earnings in 2020 included lower crude oil and natural gas realizations, higher impairment and write-off charges, and lower crude oil sales volumes. These factors were influenced by external market conditions, including the impact of the COVID-19 pandemic and lower commodity prices.",4.5,0.9036772067259541,1.0
What were the major impairments and write-offs recorded by Chevron in 2020?,"In 2020, Chevron recorded major impairments and write-offs primarily related to its upstream assets, particularly in the context of the COVID-19 pandemic and the resulting sharp decline in oil prices. The company reported an impairment charge of $2.1 billion in the fourth quarter of 2020, primarily driven by impairments in its upstream assets, including the U.S. onshore assets such as the Permian Basin and the Gulf of Mexico. These impairments were due to the sustained low oil prices and reduced demand for energy. Additionally, Chevron recorded an impairment of $1.3 billion in the third quarter of 2020, primarily related to its upstream assets in the U.S. onshore and in the Gulf of Mexico. These impairments were a result of the same market conditions.

Chevron also reported a write-down of $1.2 billion in the fourth quarter of 2020 related to its upstream assets in the United States, as well as a write-down of $1.4 billion in the third quarter of 2020 related to its upstream assets in the Gulf of Mexico. These write-downs were due to the prolonged period of low oil prices and the impact of the pandemic on global energy demand.

Overall, Chevron recorded a total of $4.6 billion in impairments and write-offs in 2020, primarily related to its upstream assets.","In 2020, Chevron recorded major impairments and write-offs primarily due to downward revisions to its oil and gas price outlook. The company fully impaired its investments in Petropiar and Petroboscan in Venezuela, resulting in a total impairment of $2.6 billion.",4.0,0.7754011196047581,1.0
What was the impact of the Noble Energy acquisition on Chevron's financial position?,I don't know.,"The acquisition of Noble Energy added $7.7 billion in assets sales proceeds and increased Chevron's debt by assuming total debt, including finance lease obligations, with a fair value of approximately $9.4 billion. This acquisition provided Chevron with low-cost proved reserves and attractive undeveloped resources.",1.0,0.23014854567607843,0.0
What are the potential impacts of changes in tax laws or regulations on the company's financial condition?,"Changes in tax laws or regulations can impact a company's financial condition by affecting its tax expenses, cash flow, profitability, and overall financial planning. For example, an increase in corporate tax rates may reduce net income and retained earnings, while tax incentives or deductions may improve cash flow and encourage investment. Additionally, changes may alter deferred tax assets or liabilities, impact financial statement reporting, and influence strategic decisions such as capital expenditures or dividend policies.","Changes in tax laws or regulations, such as the Tax Cuts and Jobs Act of 2017 and the California Consumer Privacy Act (CCPA), could increase the company's compliance burdens and costs, potentially impacting its financial condition and results of operations.",4.5,0.6451126001687972,1.0
"What is the current status of the Company's investment in Oak Therapeutics, Inc.?",I don't know.,"On April 15, 2019, the Company entered into a Termination and Release Agreement with Oak Therapeutics to surrender all of its Oak shares to Oak and terminate any rights the Company might have to acquire additional shares or interest in Oak. The parties terminated all contractual relationships between them. As of the date of deconsolidation, Oak had a negative net asset, which resulted in a gain of $0.08 million.",1.0,0.21349505899307142,1.0
How does the Company assess the recoverability of its long-lived assets?,I don't know.,"The Company assesses the carrying value of its long-lived asset groups when indicators of impairment exist and recognizes an impairment loss when the carrying amount of a long-lived asset is not recoverable when compared to undiscounted cash flows expected to result from the use and eventual disposition of the asset. Indicators of impairment include significant underperformance relative to historical or projected future operating results, significant changes in the Company’s use of the assets or in its business strategy, loss of or changes in customer relationships, and significant negative industry or economic trends.",1.0,0.26275977651663723,0.0
How does our dependence on Merck for collaboration affect our business and financial condition?,I don't know.,"Our dependence on Merck involves risks such as Merck potentially not extending the research phase of the collaboration, deciding not to proceed with certain product candidates, or terminating the collaboration, which could delay or preclude our ability to complete research and development programs and materially adversely affect our business and financial condition.",1.0,0.2384685344716723,0.0
"What are the potential impacts of disease outbreaks, epidemics, and pandemics, such as COVID-19, on our business operations?","Disease outbreaks, epidemics, and pandemics like COVID-19 can significantly disrupt business operations by causing workforce shortages due to illness or quarantine, disrupting supply chains, reducing consumer demand, increasing operational costs, and necessitating shifts to remote work or altered business models. They may also lead to temporary closures, travel restrictions, and uncertainty in markets, impacting financial performance and long-term planning.","Disease outbreaks like COVID-19 can disrupt our operations, delay clinical trials, impact patient enrollment, and increase costs. They can also affect our ability to obtain regulatory approvals and commercialize our product candidates, thereby harming our business, financial condition, and results of operations.",4.5,0.7204232831461757,1.0
What are the risks associated with our international operations and expansion plans?,I don't know.,"Risks include compliance with varying regulatory requirements, potential difficulties in obtaining and maintaining regulatory approvals, challenges in managing foreign operations, and exposure to financial risks such as currency exchange rate fluctuations and longer payment cycles.",1.0,0.2562880241820615,0.0
What is the potential impact if the company fails to complete its initial business combination by the deadline?,"If the company fails to complete its initial business combination by the deadline, it may be required to liquidate and return the trust proceeds to its public shareholders. The company would cease operations, and the funds would be distributed to investors, potentially resulting in a loss of investment for shareholders.","If the company fails to complete its initial business combination by the deadline, it will cease all operations except for winding up, redeem public shares, and dissolve, resulting in shareholders receiving only their pro rata portion of the funds in the trust account, which may be less than $10.10 per share, and the warrants will expire worthless.",4.0,0.8659669915376119,1.0
What are the key components of the decoupling mechanism for the Utilities?,I don't know.,"The key components of the decoupling mechanism for the Utilities include monthly revenue balancing account (RBA) revenues or refunds, rate adjustment mechanism (RAM) revenues, major project interim recovery (MPIR), performance incentive mechanisms (PIMs), and an earnings sharing mechanism (ESM).",1.0,0.1652649135708442,0.0
How does HEI manage its investment securities portfolio?,I don't know.,"HEI manages its investment securities portfolio by classifying investments as held-to-maturity (HTM), trading, or available-for-sale (AFS), and by using fair value estimates obtained from independent third-party pricing services or brokers.",1.0,0.23860886990659247,1.0
What is the significance of the performance-based regulation (PBR) framework approved by the PUC?,"The performance-based regulation (PBR) framework approved by the PUC (Public Utilities Commission) is significant because it aligns utility company incentives with public interests by rewarding performance rather than infrastructure investment. It encourages efficiency, innovation, and the achievement of specific goals such as reliability, customer service, and environmental sustainability. This framework shifts the focus from traditional cost-of-service regulation to outcomes-based metrics, promoting long-term benefits for consumers and the broader energy system.","The PBR framework approved by the PUC provides a new regulatory model that aims to provide financial stability to the Utilities and facilitate the transition to a clean energy economy. It includes mechanisms such as the annual revenue adjustment (ARA), earnings sharing mechanism (ESM), and performance incentive mechanisms (PIMs) to ensure efficient and effective operations.",5.0,0.782549749007172,1.0
How does HEI manage its short-term borrowings?,I don't know.,"HEI manages its short-term borrowings through commercial paper and bank term loans. As of December 31, 2020, HEI had $65 million of commercial paper outstanding and a $65 million 364-day term loan from a syndicate of two banks. HEI also maintains credit facilities to support its short-term commercial paper program and working capital needs.",1.0,0.2529913524356838,0.0
How does HEI manage its long-term debt?,I don't know.,HEI manages its long-term debt by issuing unsecured senior notes through private placements and maintaining credit facilities to support its short-term commercial paper program and working capital needs. HEI also ensures compliance with financial covenants and customary conditions in its debt agreements.,1.0,0.1982251510495506,0.0
What are the unique properties of CSN therapeutics?,I don't know.,"CSN therapeutics are comprised of atoms of transition elements that, when assembled in nanocrystalline form, possess unusually high, unique catalytic activities not present in those same elements in bulk form. These nanocatalytic activities drive, support, and maintain beneficial metabolic and energetic intercellular reactions within diseased, stressed, and damaged cells.",1.0,0.2104819131556972,0.0
What is the patent-protected position of Clene?,I don't know.,Clene's patent-protected position affords it the potential to develop a broad and deep pipeline of novel CSN therapeutics to address a range of diseases with high impact on human health.,1.0,0.1644299093638659,0.5
What is the Clene Approach to drug development?,I don't know.,"The Clene approach to drug development is innovation-focused and scientifically driven, involving the creation of highly active therapeutic nanocatalysts with novel mechanisms of action resulting from proprietary advances in nanotechnology, plasma and quantum physics, biochemistry, and materials science.",1.0,0.21677198143734158,0.0
What is the market opportunity for CSN therapeutics in neurodegenerative diseases?,I don't know.,"Despite the urgent demand for treatments and the tremendous market opportunities for neurodegenerative disease therapeutics, effective treatments are limited. If the clinical studies underway provide evidence of remyelination or demonstrate improved neurological function, CSN therapeutics will have significant commercial sales potential in treating MS, PD, or ALS.",1.0,0.19057593453683266,0.0
What is the primary responsibility of the management of the Federal Home Loan Bank of Boston regarding internal control over financial reporting?,"The primary responsibility of the management of the Federal Home Loan Bank of Boston regarding internal control over financial reporting is to establish and maintain effective internal control over financial reporting to ensure the reliability of financial reporting and the preparation of financial statements in accordance with generally accepted accounting principles (GAAP). This includes designing, implementing, and monitoring controls to provide reasonable assurance regarding the accuracy and completeness of financial records and the effectiveness of financial reporting processes.",The management of the Federal Home Loan Bank of Boston is responsible for establishing and maintaining adequate internal control over financial reporting to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles in the United States of America.,5.0,0.8612452457389985,1.0
How does the Federal Home Loan Bank of Boston manage its credit risk exposure from advances?,"The Federal Home Loan Bank of Boston manages its credit risk exposure from advances primarily through rigorous underwriting standards, collateral requirements, and ongoing risk monitoring. Advances are typically secured by qualified collateral, such as residential and commercial mortgages, government securities, and other eligible assets, which helps mitigate credit risk. The Bank also employs stress testing, collateral valuation, and exposure limits to manage and limit potential losses. Additionally, it maintains a reserve for credit losses and adheres to regulatory guidelines set by the Federal Housing Finance Agency (FHFA).","The Federal Home Loan Bank of Boston manages its credit risk exposure from advances through an integrated approach that includes establishing credit limits for each borrower, ongoing review of each borrower's financial condition, and collateral and lending policies that limit risk of loss while balancing borrowers' needs for a reliable source of funding.",4.5,0.8222236855916257,1.0
What are the key features of the Mortgage Partnership Finance® (MPF®) program through which the Federal Home Loan Bank of Boston invests in mortgage loans?,"The Mortgage Partnership Finance® (MPF®) program, administered by the Federal Home Loan Bank of Boston, is a mortgage lending and investment program that allows member institutions to sell mortgage loans to the Bank while retaining certain servicing and credit risk responsibilities. Key features of the MPF® program include:

1. **Collaborative Partnership**: The program enables FHLBank Boston to partner with qualified member institutions to purchase mortgage loans, supporting home financing and community development.

2. **Loan Origination and Purchase**: Member institutions originate mortgage loans, which are then eligible for purchase by the FHLBank, provided they meet the program’s underwriting and credit quality standards.

3. **Risk Sharing**: The MPF® program includes various risk-sharing structures, such as full-coverage and shared-risk options, where the member institution may retain a portion of credit risk, promoting responsible lending practices.

4. **Conforming Loans**: The program primarily focuses on conforming mortgage loans that meet Fannie Mae or Freddie Mac guidelines, promoting liquidity and affordability in the housing market.

5. **Servicing Retention**: Member institutions typically retain servicing rights, allowing them to continue collecting payments and providing customer support.

6. **FHLBank Investment**: The FHLBank invests in these loans, enhancing liquidity for member institutions and supporting the availability of mortgage credit.

7. **Regulatory Compliance**: Loans must comply with federal, state, and program-specific regulations, including fair lending practices and underwriting standards.

8. **Support for Affordable Housing**: The MPF® program supports affordable housing initiatives, aligning with the FHLBank’s mission to advance community investment.

These features enable the FHLBank of Boston to provide capital support for mortgage lending while working in partnership with member institutions to promote homeownership and community development.",The MPF program allows the Federal Home Loan Bank of Boston to invest in conventional and government-insured or -guaranteed residential fixed-rate mortgage loans purchased from participating financial institutions. These loans are either guaranteed or insured by federal agencies or credit-enhanced by the related entity that sold the loan.,4.5,0.7601758357226231,1.0
How does the company's significant indebtedness affect its financial flexibility?,"The company's significant indebtedness reduces its financial flexibility by limiting its ability to obtain additional financing, increasing interest expenses, and constraining its capacity to invest in growth opportunities or respond to unexpected challenges. High debt levels may also lead to tighter credit terms from lenders and reduce investor confidence.","Significant indebtedness increases the risk of loss, reduces cash available for distributions, and may limit the company's ability to refinance debt or pursue new investments, potentially affecting its financial condition and results of operations.",4.5,0.7676133637595014,1.0
How does the lack of liquidity in the company's investments affect its business?,"The lack of liquidity in a company's investments can negatively affect its business by limiting its ability to quickly convert assets into cash to meet short-term obligations, such as paying bills, covering operating expenses, or responding to unexpected financial needs. This can lead to cash flow problems, increased reliance on external financing, higher borrowing costs, and potential damage to the company's creditworthiness. Additionally, illiquid investments may hinder the company's flexibility in pursuing new opportunities or adapting to market changes.","The lack of liquidity in the company's investments makes it difficult to sell assets quickly if needed, which could limit its ability to respond to changes in economic conditions or meet financial obligations.",5.0,0.7796840841826729,1.0
"What was the outcome of Rayonier Inc.'s management assessment of internal control over financial reporting as of December 31, 2020?",I don't know.,"Based on their evaluation under the criteria set forth in the Internal Control - Integrated Framework, management concluded that their internal control over financial reporting was effective as of December 31, 2020.",1.0,0.2273821435717716,0.5
What are the inherent limitations of internal control over financial reporting?,"The inherent limitations of internal control over financial reporting include:

1. **Human Error**: Mistakes in judgment, carelessness, or simple errors in processing can compromise controls.
2. **Management Override**: Senior management may override controls for personal gain or to manipulate financial results.
3. **Collusion**: Two or more individuals may conspire to bypass controls, making it difficult to detect fraud.
4. **Cost-Benefit Constraints**: Controls are designed with cost considerations, so not all risks can be mitigated due to expense.
5. **Complexity and Change**: As business environments become more complex or undergo rapid change, controls may not keep pace.
6. **Judgment and Subjectivity**: Certain financial reporting decisions rely on estimation and judgment, which may introduce variability.

These limitations mean that even effective internal control systems cannot provide absolute assurance against material misstatement.","The inherent limitations of internal control over financial reporting include the possibility of misstatements due to error or fraud not being prevented or detected on a timely basis. Additionally, projections of any evaluation of effectiveness to future periods are subject to the risk that controls may become inadequate because of changes in conditions, or that the degree of compliance with the policies or procedures may deteriorate.",5.0,0.8150709165269157,1.0
What are the reportable business segments of Rayonier Inc. after the merger with Pope Resources?,I don't know.,"After the merger with Pope Resources, Rayonier Inc. operates in six reportable segments: Southern Timber, Pacific Northwest Timber, New Zealand Timber, Timber Funds, Real Estate, and Trading.",1.0,0.174920259935982,0.0
What is the nature of the environmental remediation liabilities assumed by Rayonier Inc. in the merger with Pope Resources?,I don't know.,"In the merger with Pope Resources, Rayonier Inc. assumed environmental remediation liabilities related to potential liability associated with environmental contamination and Natural Resource Damages (NRD) in Port Gamble, Washington.",1.0,0.17594144880435306,0.0
How does Rayonier Inc. account for its investments in marketable equity securities?,"Rayonier Inc. accounts for its investments in marketable equity securities as trading securities or available-for-sale securities, depending on the company's intent and the nature of the investments. These investments are typically reported at fair value on the balance sheet, with unrealized gains and losses recognized in earnings or other comprehensive income, respectively. For the most accurate and up-to-date information, refer to Rayonier's latest annual report or Form 10-K filed with the SEC.","Rayonier Inc. accounts for its investments in marketable equity securities at fair value based on quoted prices in their active market, with both the realized and unrealized gains and losses reported in “Interest and other miscellaneous income, net.”",3.0,0.8004584971398323,1.0
"What is the primary focus of Starwood Property Trust, Inc.?","The primary focus of Starwood Property Trust, Inc. is to provide financing for real estate, primarily through debt and preferred equity investments in the U.S. and selected international markets. The company specializes in commercial real estate lending and investment, including office, multifamily, industrial, and other property types.","Starwood Property Trust, Inc. is primarily focused on originating, acquiring, financing, and managing mortgage loans and other real estate investments in both the United States and Europe.",4.5,0.8643613968032801,1.0
How has the adoption of Accounting Standards Codification Topic 326 affected the Company's accounting for expected credit losses?,I don't know.,"The adoption of ASC 326, effective January 1, 2020, changed the Company's method of accounting for expected credit losses to a current expected credit loss model (CECL), which requires the consideration of possible credit losses over the life of an instrument, as opposed to only upon the occurrence of a discrete loss event.",1.0,0.2626483549466897,0.0
How does the Company manage its exposure to interest rate risk?,I don't know.,"The Company manages its exposure to interest rate risk by using derivative financial instruments such as interest rate swaps, which are designed to economically hedge certain risks. These derivatives are not designated for hedge accounting and changes in their fair value are recorded in earnings.",1.0,0.2035298421816026,0.0
What is the significance of the fair value option election for certain financial assets and liabilities?,"The fair value option election allows entities to measure certain financial assets and liabilities at fair value, even if other accounting standards require or permit measurement at amortized cost or another basis. The significance of this election includes:

1. **Improved Financial Statement Relevance**: It provides more timely and relevant information by reflecting current market values in the financial statements.

2. **Enhanced Comparability**: By using fair value for selected items, entities can better match the measurement of assets and liabilities, improving the comparability of financial statements across reporting periods and entities.

3. **Reduction in Accounting Mismatch**: It helps mitigate mismatches between the measurement basis of related assets and liabilities (e.g., when hedging), aligning their reporting in the same way.

4. **Increased Transparency**: It offers clearer insights into an entity’s financial position and risk exposure by disclosing fair values.

5. **Voluntary Election**: The option is typically optional, allowing entities to choose based on their specific circumstances, such as the nature of their operations or risk management strategies.

However, the election must be made on an instrument-by-instrument basis and is generally applied consistently unless a specific exemption applies. Once elected, the choice is irrevocable for that instrument.","The fair value option election allows the Company to make an irrevocable election to measure certain eligible financial assets and liabilities at fair value. Unrealized gains and losses on items for which the fair value option has been elected are reported in earnings, which helps to mitigate accounting mismatches between the carrying value of the instruments and the related assets and liabilities that the Company consolidates at fair value.",5.0,0.7203768166831072,1.0
How does the Company account for acquisitions of real estate with in-place leases?,"The Company accounts for acquisitions of real estate with in-place leases by allocating the purchase price to the tangible and identifiable intangible assets and liabilities based on their fair values at the acquisition date. This includes the value of the property itself, as well as the value of in-place leases (such as lease acquisition costs, tenant improvements, and above- or below-market lease values), and any assumed liabilities. These values are typically determined using valuation techniques such as income, market, or cost approaches. The acquired assets and liabilities are recognized at their fair values on the acquisition date, and any excess of the purchase price over the net fair value of identifiable assets acquired and liabilities assumed is recorded as goodwill. The allocation of the purchase price is performed in accordance with the applicable accounting standards, such as ASC 805 (Business Combinations) or IFRS 3 (Business Combinations).","For acquisitions of real estate with in-place leases where substantially all of the fair value of the assets acquired is concentrated in either a single identifiable asset or group of similar identifiable assets, the Company applies the asset acquisition provisions of ASC 805, resulting in the acquired properties being recognized initially at their purchase price inclusive of acquisition costs.",4.0,0.7013761493928672,1.0
What is the Company's approach to managing credit risk in its investment portfolio?,I don't know.,"The Company manages credit risk by regularly evaluating the extent and impact of any credit deterioration associated with the performance and/or value of the underlying collateral, the financial and operating capability of the borrower, and the overall economic environment. It utilizes third-party database services to provide industry losses as benchmarks for determining expected credit losses.",1.0,0.2423928217546343,0.0
How has Stifel Financial Corp. adopted new accounting standards for credit losses?,"Stifel Financial Corp. adopted the Financial Accounting Standards Board's (FASB) Accounting Standards Update (ASU) 2016-13, ""Financial Instruments — Credit Losses (Topic 326),"" which introduced the Current Expected Credit Loss (CECL) model. Under this standard, the company measures credit losses on financial assets held at amortized cost based on expected credit losses over the life of the asset, rather than recognizing losses only when they are deemed probable (the ""incurred loss"" model). Stifel implemented this change as of January 1, 2020, and updated its accounting policies, systems, and internal controls to reflect the new requirements. This adoption resulted in an increase in the allowance for credit losses on loans, reflecting the forward-looking nature of CECL.","Stifel Financial Corp. adopted the new accounting standard for credit losses on January 1, 2020, which requires the measurement of the allowance for credit losses to be based on management’s best estimate of lifetime expected credit losses inherent in the Company’s relevant financial assets.",5.0,0.7834120846561796,1.0
How does Stifel Financial Corp. manage its off-balance sheet credit risk?,I don't know.,"Stifel Financial Corp. manages its off-balance sheet credit risk through various strategies, including position and credit limits, continuous monitoring of collateral, requiring additional collateral when appropriate, and using interest rate derivative contracts to manage exposures arising from business activities.",1.0,0.20163116308148993,0.0
What are the key factors considered in the valuation of Stifel Financial Corp.'s financial instruments?,"The key factors considered in the valuation of Stifel Financial Corp.'s financial instruments include market interest rates, credit risk, liquidity, fair value hierarchy (Level 1, 2, or 3 inputs), expected credit losses, and the timing and amount of cash flows. These factors are assessed in accordance with accounting standards such as ASC 820 (Fair Value Measurement) and ASC 320 (Investments – Debt and Equity Securities).","The key factors considered in the valuation of Stifel Financial Corp.'s financial instruments include observable market prices, contractual terms, market parameters, credit ratings, and the value of underlying collateral. The valuation techniques used vary depending on the level of pricing observability.",4.0,0.8946997620123726,1.0
How does Stifel Financial Corp. report its quarterly financial information?,"Stifel Financial Corp. reports its quarterly financial information through press releases and filings with the U.S. Securities and Exchange Commission (SEC). The company typically issues a press release announcing its quarterly results, which includes key financial metrics and performance highlights. These results are also detailed in the Form 10-Q, a quarterly report filed with the SEC. The Form 10-Q contains comprehensive financial statements, management's discussion and analysis (MD&A), and other disclosures required by the SEC. Investors can access these filings on the SEC's EDGAR database and Stifel's investor relations website.","Stifel Financial Corp. reports its quarterly financial information in a summarized format, providing key financial metrics such as revenues, net income, and earnings per share for each quarter of the fiscal year.",5.0,0.8256761573492344,1.0
What is the primary method used to evaluate the effectiveness of the Partnership’s internal control over financial reporting?,I don't know.,The Partnership uses the framework set forth in the report entitled “Internal Control-Integrated Framework” (2013) issued by the Committee of Sponsoring Organizations of the Treadway Commission (COSO).,1.0,0.194997278889886,0.0
What is the purpose of the commercial paper program maintained by the Partnership?,I don't know.,"The commercial paper program allows the Partnership to issue up to $3.0 billion in privately placed, unsecured commercial paper notes, which are primarily used for short-term financing needs such as working capital.",1.0,0.23457731056086528,1.0
How does the Partnership allocate net income for partners’ capital presentation purposes?,I don't know.,Net income is allocated 100% to common unitholders after giving effect to income allocations for cash distributions to Series A preferred unitholders and guaranteed payments attributable to Series B preferred unitholders.,1.0,0.2113137008197204,0.0
"How did Loews Corporation assess the effectiveness of its internal control over financial reporting as of December 31, 2020?",I don't know.,Loews Corporation's management assessed the effectiveness of its internal control over financial reporting using the criteria set forth by the Committee of Sponsoring Organizations of the Treadway Commission in Internal Control - Integrated Framework (2013).,1.0,0.26731788654861627,0.0
"What significant accounting changes did Loews Corporation adopt on January 1, 2020?",I don't know.,"On January 1, 2020, Loews Corporation adopted ASU 2016-13, ""Financial Instruments-Credit Losses (Topic 326): Measurement of Credit Losses on Financial Instruments,"" which required changes to the recognition of credit losses on financial instruments not accounted for at fair value through net income.",1.0,0.2611013901884776,0.0
How did the adoption of ASU 2016-13 affect Loews Corporation's financial statements?,I don't know.,"The adoption of ASU 2016-13 resulted in a $5 million decrease in Retained earnings, after tax and noncontrolling interests, and the establishment of an allowance for credit losses of $6 million for available-for-sale fixed maturity securities that were purchased with credit deterioration.",1.0,0.2239599262761778,0.0
"What was the impact of Diamond Offshore's deconsolidation on Loews Corporation's financial statements for the year ended December 31, 2020?",I don't know.,"The deconsolidation of Diamond Offshore resulted in the recognition of a loss of $1.2 billion ($957 million after tax) during the year ended December 31, 2020, which is reported within Investment gains (losses) on the Consolidated Statements of Operations.",1.0,0.279051354560159,0.0
How did Boardwalk Pipelines' acquisition of common units affect its financial position?,I don't know.,"Boardwalk Pipelines' acquisition of common units resulted in an increase to Additional paid-in capital of $658 million, an increase to deferred income tax liabilities of $213 million, and a decrease to AOCI of $29 million.",1.0,0.1869681199086046,0.0
What are the potential risks associated with relying on third-party manufacturers for the supply of our product candidates?,"Relying on third-party manufacturers for the supply of product candidates can pose several potential risks, including:

1. **Supply Chain Disruptions**: Dependence on external manufacturers can lead to delays or interruptions due to production issues, natural disasters, or geopolitical events.

2. **Quality Control Issues**: Third-party manufacturers may not maintain consistent quality standards, potentially leading to product defects, regulatory non-compliance, or safety concerns.

3. **Intellectual Property (IP) Risks**: Sharing proprietary processes or formulations with third parties may expose sensitive IP to theft or unauthorized use.

4. **Regulatory Non-Compliance**: Manufacturers may fail to comply with regulatory standards (e.g., FDA, EMA), leading to delays in product approval, recalls, or legal penalties.

5. **Cost Fluctuations**: Contract manufacturers may change pricing or impose additional fees, impacting production costs and profitability.

6. **Limited Control and Flexibility**: Reduced oversight can limit the ability to adapt quickly to changes in demand, technology, or market conditions.

7. **Reputation Risk**: Any failure or misstep by the manufacturer can negatively impact the reputation of the parent company.

8. **Long-Term Availability**: Over-reliance on a single manufacturer may create supply vulnerabilities if the vendor discontinues production or goes out of business.

9. **Contractual Risks**: Inadequate or poorly structured agreements may lead to disputes, delays, or inability to enforce performance standards.

10. **Scalability Challenges**: Third-party manufacturers may lack the capacity to scale production quickly to meet increased demand.

These risks underscore the importance of thorough vendor evaluation, strong contractual agreements, continuous monitoring, and contingency planning.","Relying on third-party manufacturers exposes us to risks including potential delays in product supply, quality control issues, and dependency on the manufacturers' compliance with regulatory requirements. Any failure by these manufacturers could delay our product development and commercialization efforts.",5.0,0.8491714826337236,1.0
How does the COVID-19 pandemic potentially impact the company's business operations?,I don't know.,"The COVID-19 pandemic could have a material adverse impact on the company's business, financial condition, and results of operations, including disruptions to clinical trials, manufacturing, supply chain, and commercialization efforts, as well as potential delays in regulatory approvals and market introduction of products.",1.0,0.27040816087718184,0.0
How does the company's reliance on third-party manufacturers affect its operations?,I don't know.,"The company's reliance on third-party manufacturers for the production of octreotide capsules exposes it to risks such as potential supply disruptions, quality control issues, and regulatory compliance challenges. Any failure by these manufacturers to meet quality standards or regulatory requirements could delay product development and commercialization, leading to increased costs and potential loss of market opportunities.",1.0,0.15959642790278342,0.0
"What are the financial implications of the company's Revenue Interest Financing Agreement with Healthcare Royalty Partners IV, L.P.?",I don't know.,"The Revenue Interest Financing Agreement imposes significant financial obligations on the company, including tiered quarterly royalty payments based on product revenues, potential gross-up payments, and restrictions on incurring additional indebtedness. These obligations could limit the company's financial flexibility and increase its operating costs, potentially impacting its ability to invest in growth initiatives and maintain profitability.",1.0,0.12075817409225317,0.0
How does the company plan to address the risk of product liability lawsuits?,I don't know.,"The company maintains product liability insurance coverage to mitigate the financial impact of potential product liability claims. However, it recognizes that insurance coverage may not be sufficient to cover all costs and liabilities that could arise from such claims, and it may face significant legal expenses, reputational damage, and potential financial losses if it is unable to defend against or settle these claims successfully.",1.0,0.26476811794287397,0.5
How does the company's dependence on a limited group of suppliers and manufacturers impact its business?,"The company's dependence on a limited group of suppliers and manufacturers can increase supply chain risk, reduce flexibility, and lead to higher costs if those suppliers face disruptions, price increases, or quality issues. It may also limit the company's ability to innovate or negotiate favorable terms, potentially affecting profitability and customer satisfaction.","The company may incur significant product development costs or experience material delivery delays if there is an interruption in supply from any one of these suppliers or manufacturers, which could materially impact sales of its products.",4.5,0.6476944187606761,1.0
"What are the implications of the company being a ""controlled company"" under Nasdaq rules?","Under Nasdaq rules, a ""controlled company"" is a company where more than 50% of the voting power is controlled by a single shareholder, director, or group. The implications include:

1. **Exemption from Certain Corporate Governance Requirements**: Controlled companies are exempt from the Nasdaq requirement to have a majority of independent directors on their board of directors.

2. **Exemption from Independent Compensation Committee**: They are not required to have an independent compensation committee.

3. **Exemption from Independent Nomination Committee**: They are not required to have an independent nominating committee.

4. **Flexibility in Board Structure**: The company may have a board structure that does not comply with full independence requirements, allowing the controlling shareholder to exert greater influence over board decisions.

These exemptions are intended to provide flexibility to companies that are closely held or controlled by a single entity, recognizing that their governance structure may differ from fully independent public companies. However, this may also raise concerns about governance and minority shareholder protection.","As a controlled company, the company qualifies for exemptions from certain corporate governance requirements, which may limit the protections afforded to shareholders and could impact the company's stock price and trading volume.",5.0,0.7028384725611206,1.0
What is the primary risk factor mentioned regarding investment in the company's shares?,I don't know.,"The primary risk factor mentioned is that an investment in the company's shares involves a high degree of risk, and the occurrence of any of the risks listed could have a material adverse effect on the company's business, financial condition, results of operations, and future growth prospects.",1.0,0.30218719142665185,0.0
How has the COVID-19 pandemic impacted the company's business operations and clinical development timelines?,I don't know.,"The COVID-19 pandemic has affected the company's business operations and clinical development timelines by impacting patient recruitment, enrollment, and follow-up visits at clinical sites. Government orders and restrictions to control the spread of the disease have also caused delays and uncertainties in the company's operations.",1.0,0.28633078421065944,0.0
What measures has the company taken to protect its intellectual property rights?,I don't know.,"The company seeks to protect its intellectual property rights by filing patent applications in the United States and abroad, entering into confidentiality agreements with parties who have access to its proprietary information, and maintaining physical and electronic security of its information technology systems.",1.0,0.2686104491760994,0.5
What are the risks associated with the company's reliance on third-party manufacturers for the production of its product candidates?,I don't know.,"The risks include the inability to meet product specifications and quality requirements consistently, delays in obtaining sufficient manufacturing capacity, potential non-compliance with regulatory requirements, and the possibility of increased costs and operational challenges if the company needs to find alternative manufacturers.",1.0,0.24731211627077887,0.0
"What was the opinion of KPMG LLP on the Company's internal control over financial reporting as of December 31, 2020?",I don't know.,"In their opinion, KPMG LLP stated that the Company maintained, in all material respects, effective internal control over financial reporting as of December 31, 2020, based on the COSO framework.",1.0,0.22890351721756189,1.0
How did the Company support its liquidity and capital resources during the crisis in March 2020?,I don't know.,The Company supported its liquidity and capital resources by issuing four series of senior notes totaling ¥57.0 billion and issuing $1.0 billion in senior notes through public debt offerings under its U.S. shelf registration statement. The Company also has available liquidity in its unsecured revolving credit facilities of $1.0 billion and ¥100.0 billion and currently has no borrowings under either of these facilities.,1.0,0.25291592082341174,0.0
What are the significant accounting policies of Aflac Incorporated?,"Aflac Incorporated's significant accounting policies are detailed in its annual reports and financial statements, primarily in the notes to the consolidated financial statements. Key policies typically include:

1. **Revenue Recognition**: Aflac recognizes revenue when the insured event occurs or when the policy coverage period has passed, depending on the product type. For annuities, revenue is recognized when the contract becomes effective, and for life insurance, it is recognized over time as premiums are collected and benefits are provided.

2. **Insurance Contracts**: Aflac uses the retrospective approach to account for insurance contracts, recognizing future profits based on estimated premiums, expenses, and claim costs over the life of the contract. Policyholders' benefits and claim liabilities are recorded in the balance sheet.

3. **Fair Value Measurements**: Financial instruments, including investments and derivatives, are measured at fair value using observable market data. Fair value is determined based on the hierarchy of inputs (Level 1, 2, and 3).

4. **Investments**: Investments are reported at fair value. Equity securities are recorded at fair value with changes recognized in earnings, while debt securities are categorized as available-for-sale and reported at fair value, with unrealized gains and losses in other comprehensive income.

5. **Deferred Acquisition Costs (DAC)**: Aflac capitalizes certain costs directly related to acquiring new business, such as commissions and underwriting expenses. These costs are amortized over the estimated life of the insurance contracts.

6. **Policyholder Benefits and Claims**: Benefits are accrued based on estimates of future claims and losses, including reserves for future policy benefits and claims incurred but not reported (IBNR).

7. **Reinsurance**: Aflac uses reinsurance to manage risk. Premiums and benefits are recognized net of reinsurance ceded.

8. **Income Taxes**: Aflac accounts for income taxes using the asset and liability method, recognizing deferred tax assets and liabilities for temporary differences between financial reporting and tax bases.

9. **Goodwill and Intangible Assets**: Goodwill is tested annually for impairment, and intangible assets are amortized over their estimated useful lives.

10. **Impairment of Long-Lived Assets**: Aflac assesses long-lived assets for impairment whenever events or changes in circumstances indicate that the carrying value may not be recoverable.

For the most accurate and up-to-date information, refer to the latest Form 10-K and financial statements filed with the SEC.","The significant accounting policies of Aflac Incorporated include foreign currency translation, insurance revenue and expense recognition, cash and cash equivalents, investments, deferred policy acquisition costs, goodwill, policy liabilities, reinsurance, income taxes, treasury stock, share-based compensation, earnings per share, and reclassifications.",5.0,0.8019084621756978,1.0
How does the Company account for foreign currency translation?,I don't know.,"The functional currency of Aflac Japan is the Japanese yen. The Company translates its yen-denominated financial statement accounts into U.S. dollars as follows: assets and liabilities are translated at end-of-period exchange rates, realized gains and losses on security transactions are translated at the exchange rate on the trade date, and other revenues, expenses, and cash flows are translated using average exchange rates for the period. The resulting currency translation adjustments are reported in accumulated other comprehensive income.",1.0,0.31046136621443987,0.0
What is the basis for KPMG LLP's opinion on the consolidated financial statements?,"The basis for KPMG LLP's opinion on the consolidated financial statements is the audit conducted in accordance with U.S. generally accepted auditing standards. These standards require that the audit be planned and performed to obtain reasonable assurance about whether the financial statements are free of material misstatement, whether due to fraud or error. KPMG LLP evaluates the financial statements, including the related disclosures, and assesses the overall presentation, including the adequacy of disclosures, to form an opinion on whether the statements present fairly, in all material respects, the financial position, results of operations, and cash flows of the entity in accordance with U.S. generally accepted accounting principles.","KPMG LLP's opinion on the consolidated financial statements is based on their audits conducted in accordance with the standards of the PCAOB. Those standards require that they plan and perform the audit to obtain reasonable assurance about whether the consolidated financial statements are free of material misstatement, whether due to error or fraud.",4.0,0.8956711459450731,1.0
How did the Company support its liquidity and capital resources during the crisis in March 2020?,I don't know.,The Company supported its liquidity and capital resources by issuing four series of senior notes totaling ¥57.0 billion and issuing $1.0 billion in senior notes through public debt offerings under its U.S. shelf registration statement. The Company also has available liquidity in its unsecured revolving credit facilities of $1.0 billion and ¥100.0 billion and currently has no borrowings under either of these facilities.,1.0,0.25291592082341174,0.0
What are the significant accounting policies of Aflac Incorporated?,"Aflac Incorporated's significant accounting policies include:

1. **Revenue Recognition**: Revenue is recognized when the insurance coverage is provided, primarily through the recognition of premiums earned over the policy term. For annuities and other contracts with savings components, revenue is recognized when the insurer has fulfilled its performance obligations.

2. **Premiums and Deposit-Type Contracts**: Premiums are recorded as revenue when earned over the policy period. Deposit-type contracts, such as annuities, are accounted for using the deposit method, with deferred acquisition costs and policyholder deposits recorded as liabilities.

3. **Deferred Acquisition Costs**: Acquisition costs, such as commissions and underwriting expenses, are capitalized and amortized over the life of the related policies, in proportion to the estimated gross profits.

4. **Policyholder Liabilities**: These include reserves for future policy benefits and claims, which are determined using actuarial methods and assumptions about future mortality, morbidity, lapse rates, and investment returns.

5. **Investments**: Investments are classified as either available-for-sale or held-to-maturity and are recorded at fair value or amortized cost. Fair value changes are recorded in other comprehensive income unless they are deemed impaired or the investment is sold.

6. **Impairment of Investments**: Impairment is recognized when the fair value of a security is less than its carrying value and a decline is deemed other-than-temporary, with the loss recorded in earnings.

7. **Income Taxes**: Aflac uses the asset and liability method to account for deferred taxes, recognizing deferred tax assets and liabilities based on the expected future tax consequences of temporary differences.

8. **Pension and Other Postretirement Benefits**: The company accounts for pension and postretirement benefits using the accrual method, with expenses based on actuarial assumptions.

9. **Earnings Per Share (EPS)**: Aflac calculates basic and diluted EPS, adjusting for stock splits and stock dividends.

10. **Fair Value Measurements**: Fair value is determined using observable market data, with levels of the fair value hierarchy (Level 1, 2, and 3) applied to classify the inputs used.

These policies are detailed in Aflac's annual reports and filings with the SEC. For the most accurate and up-to-date information, refer to Aflac’s latest 10-K filing.","The significant accounting policies of Aflac Incorporated include foreign currency translation, insurance revenue and expense recognition, cash and cash equivalents, investments, deferred policy acquisition costs, goodwill, policy liabilities, reinsurance, income taxes, treasury stock, share-based compensation, earnings per share, and reclassifications.",5.0,0.8064414105473812,1.0
How does the Company account for foreign currency translation?,I don't know.,"The functional currency of Aflac Japan is the Japanese yen. The Company translates its yen-denominated financial statement accounts into U.S. dollars as follows: assets and liabilities are translated at end-of-period exchange rates, realized gains and losses on security transactions are translated at the exchange rate on the trade date, and other revenues, expenses, and cash flows are translated using average exchange rates for the period. The resulting currency translation adjustments are reported in accumulated other comprehensive income.",1.0,0.31046136621443987,0.0
What was the outcome of the PJM Transmission Enhancement Settlement for DP&L?,I don't know.,"The PJM Transmission Enhancement Settlement resulted in a reduction of DP&L’s transmission costs through PJM, including credits to reimburse DP&L for amounts overcharged in prior years, which will be passed to customers through the TCRR.",1.0,0.14083316281182018,0.5
What was the impact of the adoption of ASC 326 on DP&L's financial statements in 2020?,I don't know.,"The adoption of ASC 326, which updates the impairment model for financial assets, did not have a material impact on DP&L's Consolidated Financial Statements in 2020.",1.0,0.2780854316344257,0.0
What methods were used to determine the fair value of the acquired intangible assets in the Caesars Entertainment Corporation acquisition?,I don't know.,"The fair value of acquired intangible assets was determined using various income approaches, including the relief from royalty method and excess earnings method.",1.0,0.18380168855162654,0.5
What were the key terms of the CEI Revolving Credit Facility?,I don't know.,"The CEI Revolving Credit Facility provided for a five-year senior secured revolving credit facility in an aggregate principal amount of $1.2 billion, with interest rates based on LIBOR or a base rate plus an applicable margin, and a commitment fee on unused commitments.",1.0,0.2314731807694298,0.0
How did the Company's annual goodwill and indefinite-lived intangible asset impairment analysis result in 2020?,I don't know.,"The Company recognized impairment charges in the Regional segment related to goodwill and trade names totaling $100 million and $16 million, respectively, due to declines in recent performance and the expected impact on future cash flows as a result of COVID-19.",1.0,0.226113285027436,0.0
What was the nature of the litigation involving Harrah’s New Orleans and the Department of Revenue?,I don't know.,"Harrah’s New Orleans was involved in litigation with the Department of Revenue related to sales taxes on hotel rooms, parking, and entertainment complimentaries for the periods from 2004 through 2016. The litigation is ongoing, and the Company has accrued contingent liabilities of $43 million as of December 31, 2020.",1.0,0.22101463912135255,0.0
What were the key terms of the Golf Course Use Agreement with VICI Properties L.P.?,I don't know.,"The Golf Course Use Agreement with VICI Properties L.P. provided for an annual payment of $10 million, an annual use fee of $3 million, and certain per-round fees, with a 35-year term inclusive of all renewal periods.",1.0,0.27446107693275146,0.5
What is the primary responsibility of Meredith management as stated in the financial report?,I don't know.,"Meredith management is responsible for the preparation, integrity, and objectivity of the financial information included in the Annual Report on Form 10-K for the year ended June 30, 2020.",1.0,0.23669461653773252,0.0
How are the consolidated financial statements of Meredith prepared?,I don't know.,The consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America and include amounts based on informed judgments and estimates.,1.0,0.3377687903282266,0.0
Who audits the consolidated financial statements of Meredith Corporation?,I don't know.,The consolidated financial statements and the effectiveness of the Company’s internal control over financial reporting have been audited by an independent registered public accounting firm in accordance with the standards of the Public Company Accounting Oversight Board (United States).,1.0,0.22289455302652003,1.0
How did the adoption of the new leasing standard affect Meredith's financial statements?,I don't know.,"Upon adoption, $509.9 million and $541.0 million were recorded for operating lease assets and liabilities, respectively, which included the impact to previously recorded liabilities associated with deferred rent and exit or disposal costs, and impairments of certain operating lease assets related to conditions that existed prior to adoption, which resulted in a decrease of $5.8 million to retained earnings as of July 1, 2019.",1.0,0.17176673927041075,0.0
"What was the total amount of long-term debt for Meredith Corporation as of June 30, 2020?",I don't know.,"The total amount of long-term debt for Meredith Corporation as of June 30, 2020, was $2.5 billion.",1.0,0.2199602271768446,1.0
"What was the total comprehensive income (loss) for Meredith Corporation for the year ended June 30, 2020?",I don't know.,"The total comprehensive income (loss) for Meredith Corporation for the year ended June 30, 2020, was a loss of $252.3 million.",1.0,0.24492144463564178,1.0
"What was the total amount of cash and cash equivalents for Meredith Corporation as of June 30, 2020?",I don't know.,"The total amount of cash and cash equivalents for Meredith Corporation as of June 30, 2020, was $122.3 million.",1.0,0.2303889705088509,0.5
"What is the primary objective of New York City REIT, Inc.'s use of derivative financial instruments?",I don't know.,"The primary objective of using derivative financial instruments is to hedge all or a portion of the interest rate risk associated with its borrowings, to minimize risks and costs associated with the Company’s operating and financial structure, and to hedge specific anticipated transactions.",1.0,0.18137034288474002,0.0
What measures did the Company take to address potential breaches of debt service coverage and debt yield covenants?,I don't know.,"The Company is currently in breach of a debt service coverage provision and a reserve fund reserve provision under its non-recourse mortgage secured by the 1140 Avenue of the Americas property, requiring excess cash to be held in a segregated account as additional collateral under the loan. The Company is also evaluating options under the loan pursuant to the contract and other alternative options associated with the property.",1.0,0.2540745182802957,0.0
"What accounting principle did i3 Verticals, Inc. adopt on October 1, 2019, and how did it affect revenue recognition?",I don't know.,"i3 Verticals, Inc. adopted Accounting Standards Codification Topic 606, ""Revenue from Contracts with Customers,"" which changed the timing of certain revenue and expenses recognition under various arrangement types. Revenue is now recognized as each performance obligation is satisfied, and more judgment and estimates are required when applying the requirements of the new standard.",1.0,0.28482511304040603,0.0
"How does i3 Verticals, Inc. account for the costs to obtain and fulfill a contract?",I don't know.,"i3 Verticals, Inc. capitalizes incremental costs to obtain new contracts and contract renewals and amortizes these costs on a straight-line basis as an expense over the benefit period, which is generally the contract term. These costs include commissions paid to obtain new sales.",1.0,0.2585389494407841,0.0
"What is the impact of the Tax Receivable Agreement (TRA) on i3 Verticals, Inc.'s financial position?",I don't know.,"The Tax Receivable Agreement (TRA) requires i3 Verticals, Inc. to pay 85% of certain tax benefits to the Continuing Equity Owners. This has resulted in the recognition of deferred tax assets and corresponding liabilities, which affect the company's financial position by increasing its deferred tax assets and liabilities.",1.0,0.18774673685127394,0.0
"What are the quarterly trends in i3 Verticals, Inc.'s revenue and net income for the years ended September 30, 2020 and 2019?",I don't know.,"For the year ended September 30, 2020, quarterly revenue trends showed an increase from $49,431 in Q1 to $57,606 in Q4, with net income ranging from $2,151 to $6,031. For the year ended September 30, 2019, quarterly revenue increased from $42,222 in Q1 to $50,851 in Q4, with net income ranging from $1,403 to $4,585.",1.0,0.1838770062262182,0.0
"How did the adoption of ASC 842 impact the Company's balance sheet as of April 1, 2019?",I don't know.,The adoption of ASC 842 resulted in the recording of $13.3 million of additional lease liabilities and right-of-use assets to the beginning balance of the Company’s Consolidated Balance Sheet.,1.0,0.17371689821690817,0.0
"What was the impact of the Redomestication on Global Indemnity Group, LLC's class A common shares?",I don't know.,"The Redomestication resulted in the shareholders of Global Indemnity Limited becoming the holders of all of the issued and outstanding common shares of Global Indemnity Group, LLC. The class A common shares of Global Indemnity Group, LLC began trading on Nasdaq under the symbol ""GBLI"" at the commencement of trading on August 28, 2020.",1.0,0.2923107983262341,0.5
What are the principal terms of the 7.875% Subordinated Notes due 2047 issued by Global Indemnity Limited?,I don't know.,"The principal terms of the 7.875% Subordinated Notes due 2047 include:
   - Annual interest rate of 7.875%, payable quarterly.
   - Maturity date of April 15, 2047.
   - The Company has the right to redeem the notes in whole or in part on or after April 15, 2022, at a redemption price equal to 100% of the principal amount plus accrued and unpaid interest.",1.0,0.1545946260367934,0.0
How is Berkshire Hathaway Energy's operations organized?,"Berkshire Hathaway Energy's operations are organized into several business segments, primarily focused on energy generation, transmission, and distribution. The company operates through subsidiaries that manage diverse energy assets, including wind, solar, natural gas, coal, and hydroelectric power. These operations are structured geographically and functionally, with each subsidiary or region responsible for specific energy-related activities, such as power generation, transmission infrastructure, and utility services. The overall organization is overseen by a centralized management team under the leadership of Warren Buffett and his executive team.","BHE's operations are organized into eight business segments: PacifiCorp, MidAmerican Funding, NV Energy, Northern Powergrid, BHE Pipeline Group, BHE Transmission, BHE Renewables, and HomeServices.",4.0,0.5720318159896937,1.0
How many miles of transmission lines does BHE own?,I don't know.,"BHE owns approximately 36,000 miles of transmission lines.",1.0,0.2512132187129167,1.0
What is the total natural gas mains and service lines length for MidAmerican Energy?,I don't know.,"The natural gas distribution facilities of MidAmerican Energy included 24,100 miles of natural gas main and service lines as of December 31, 2020.",1.0,0.22292673899082122,0.5
How does NV Energy manage its energy supply function?,"NV Energy manages its energy supply function by integrating a diverse portfolio of power generation sources, including natural gas, solar, wind, and hydroelectric resources. The company operates and maintains power plants, purchases power from third-party generators, and utilizes long-term power purchase agreements to ensure a reliable and cost-effective energy supply. NV Energy also leverages advanced grid management technologies and demand-response programs to balance supply and demand, enhance grid stability, and support the integration of renewable energy. Additionally, the company participates in regional energy markets and coordinates with regional transmission organizations to optimize resource allocation and ensure compliance with regulatory requirements.","NV Energy manages its energy supply function through four key components: IRPs, ESPs, DRPs, and action plans, which are filed with the PUCN for approval and operate in conjunction with the PUCN-approved 20-year IRP.",4.0,0.7093353041466897,1.0
What is the Emissions Reduction and Capacity Replacement Plan for Nevada Power?,I don't know.,"The ERCR Plan includes the retirement of 255 MWs of coal-fueled generation in 2019, acquisition of 536 MWs of natural gas generating resources, execution of long-term power purchase agreements for 200 MWs of nameplate renewable energy capacity, and construction of a 15-MW solar photovoltaic facility.",1.0,0.17071017747959452,0.0
What is the role of the Northern Powergrid Distribution Companies?,"The role of Northern Powergrid Distribution Companies is to operate, maintain, and develop the electricity distribution network in their designated areas, ensuring a reliable supply of electricity to homes, businesses, and other customers. They manage the local power lines, transformers, and other infrastructure that deliver electricity from the national transmission system to end users in the northern regions of England.","The Northern Powergrid Distribution Companies build, maintain, and operate the electricity distribution network through which end-users receive a supply of electricity. They charge fees for the use of their distribution systems to the suppliers of electricity.",5.0,0.8446869982869574,1.0
What is the market area design capacity of Northern Natural Gas?,I don't know.,Northern Natural Gas' pipeline system has a Market Area design capacity of 6.3 Bcf per day.,1.0,0.19372016890182853,0.5
What is the transmission system of the Nevada Utilities part of?,I don't know.,"The Nevada Utilities' transmission system is part of the Western Interconnection, a regional grid in the United States that includes the interconnected transmission systems of 14 western states, two Canadian provinces, and parts of Mexico.",1.0,0.263456236830297,0.5
What are the key components of the energy supply planning process for the Nevada Utilities?,I don't know.,"The key components are IRPs, ESPs, DRPs, and action plans, which are filed with the PUCN for approval and operate in conjunction with the PUCN-approved 20-year IRP.",1.0,0.199649667123487,0.0
What is the impact of California Senate Bill 100 on California's RPS?,"California Senate Bill 100 (SB 100), enacted in 2018, significantly strengthens California's Renewable Portfolio Standard (RPS) by setting a target of 100% clean electricity by 2045. This law builds upon and enhances the existing RPS, which previously required 50% of retail electricity sales to come from renewable sources by 2026. SB 100 extends the timeline and sets more ambitious goals, including 60% renewable energy by 2030 and 100% greenhouse gas-free electricity by 2045. This legislation accelerates the transition to clean energy and reinforces California's leadership in climate policy.","California Senate Bill 100 increased the RPS target to 60% by 2030 and enabled a longer-term planning target for 100% of total California retail sales to come from eligible renewable energy resources and zero-carbon resources by December 31, 2045.",5.0,0.7191867526768604,1.0
What is the role of the AESO in Alberta's electricity industry?,"The role of the Alberta Electric System Operator (AESO) in Alberta's electricity industry is to manage and operate the provincial electricity system in a reliable, efficient, and impartial manner. This includes ensuring the balance between electricity supply and demand, operating the wholesale electricity market, planning for future energy needs, and ensuring the safe and secure operation of the transmission system. The AESO also facilitates market efficiency and supports the integration of renewable energy into the grid.","The AESO's mandate is defined in the Electric Utilities Act (Alberta) and requires the AESO to assess both current and future needs of Alberta's interconnected electrical system. The AESO uses the 2019 Long-term Outlook, which is the AESO's forecast of Alberta's load and generation over the next 20 years, as one input to guide the AESO in planning Alberta's transmission system.",5.0,0.7344891601684294,1.0
What is the regulatory framework for BHE's regulated subsidiaries and certain affiliates?,I don't know.,"BHE's regulated subsidiaries and certain affiliates are subject to comprehensive governmental regulation, which significantly influences their operating environment, prices charged to customers, capital structure, costs, and ultimately their ability to recover costs and earn a reasonable return on invested capital.",1.0,0.23737351441537707,0.0
How has the COVID-19 pandemic affected the company's financial performance in 2020?,I don't know.,"The COVID-19 pandemic significantly impacted the company's financial performance in 2020, leading to a decrease in net income by $98.6 million or 35%, primarily due to a $107.9 million increase in the provision for credit losses and a $37.7 million decrease in net interest income.",1.0,0.26892206033666766,0.0
"How has the Hawaii economy been impacted by COVID-19, and what are the implications for the company?","The Hawaii economy was significantly impacted by COVID-19 due to its heavy reliance on tourism, which came to a near standstill during the pandemic. With international and domestic travel restrictions, hotel occupancy rates plummeted, and many businesses in the hospitality and tourism sectors, including airlines, restaurants, and tour operators, experienced severe financial distress or closed permanently. The state also faced substantial revenue shortfalls, affecting public services and infrastructure projects.

For companies operating in Hawaii, particularly those in tourism, retail, and hospitality, the pandemic led to reduced customer traffic, supply chain disruptions, and decreased consumer spending. Many businesses had to lay off workers or reduce hours, contributing to higher unemployment rates. The recovery has been gradual, supported by federal aid, vaccination efforts, and the reopening of borders, but some sectors continue to face challenges related to labor shortages and ongoing travel uncertainty.

Implications for companies include the need to adapt business models—such as shifting to digital platforms or diversifying revenue streams—and increased reliance on cost management and financial resilience. Companies may also benefit from long-term changes in travel behavior, such as a growing interest in sustainable and local tourism. However, they must remain responsive to evolving public health guidelines and consumer preferences.","The Hawaii economy has been significantly impacted by COVID-19, with a 75.2% decrease in visitor arrivals and a 9.3% unemployment rate in December 2020. This has affected the company's operations and customer base, leading to increased credit risk and potential decreases in non-interest income.",4.5,0.6567900314675807,1.0
What are the key factors that could impact the company's profitability in future reporting periods?,I don't know.,"Key factors that could impact the company's profitability include continued adverse economic conditions due to the COVID-19 pandemic, changes in interest rates, increased credit risk, and potential decreases in non-interest income.",1.0,0.2687844347861613,0.0
How has the company's investment in high-grade investment securities evolved during 2020?,I don't know.,"The company increased its investment in high-grade investment securities, primarily collateralized mortgage obligations, with the total fair value of the investment securities portfolio rising by 49% to $6.1 billion as of December 31, 2020.",1.0,0.23785747852635114,0.0
"What is the primary purpose of the allowance for credit losses (ACL) at First Hawaiian, Inc.?","The primary purpose of the allowance for credit losses (ACL) at First Hawaiian, Inc. is to reflect the estimated credit losses inherent in the company's loan portfolio, ensuring that financial statements present a realistic assessment of potential loan losses. This allowance is established in accordance with accounting standards, such as ASC 326, to account for expected credit losses over the life of financial instruments.","The primary purpose of the ACL is to estimate and reserve for expected credit losses on loans and leases, ensuring that the net carrying value of these assets reflects the amount expected to be collected.",5.0,0.7506949774150843,1.0
"How did the adoption of the Current Expected Credit Losses (CECL) model impact First Hawaiian, Inc.'s financial statements in 2020?","The adoption of the Current Expected Credit Losses (CECL) model in 2020 impacted First Hawaiian, Inc.'s financial statements by increasing its allowance for credit losses, which resulted in a reduction in net income and equity. This change was due to the requirement to recognize expected credit losses over the life of the loans, rather than waiting for a loss to be probable, as was required under the previous incurred loss model. As a result, First Hawaiian, Inc. recorded a higher provision for credit losses, leading to a decline in earnings and a reduction in its retained earnings at the time of adoption. For detailed financial impacts, refer to the company's 2020 Annual Report or related SEC filings.","The adoption of CECL in 2020 required a cumulative effect adjustment to retained earnings as of January 1, 2020, reflecting changes in the allowance for credit losses and the reserve for unfunded commitments.",5.0,0.6001143415016931,1.0
"How does First Hawaiian, Inc. manage its interest rate risk?","First Hawaiian, Inc. manages its interest rate risk through a combination of strategies including asset-liability management, hedging instruments such as interest rate swaps, and maintaining a diversified loan and deposit portfolio. The company monitors interest rate sensitivity and adjusts its balance sheet structure to mitigate potential adverse effects from rate fluctuations. These strategies are aligned with its risk management policies and regulatory requirements.","First Hawaiian, Inc. manages interest rate risk through the use of interest rate swaps designated as either fair value hedges or cash flow hedges, which help to offset potential adverse impacts on interest expense and net interest margin.",4.0,0.8697591467572827,1.0
"What was the impact of the Visa Class B restricted shares on First Hawaiian, Inc.'s financial statements in 2020?",I don't know.,"The Visa Class B restricted shares resulted in a revaluation adjustment, leading to losses in other noninterest income of $4.8 million in 2020, as the Company made monthly payments based on changes in Visa's conversion rate.",1.0,0.2649294291452156,0.0
"What are the regulatory capital requirements for First Hawaiian, Inc., and how did the company perform against these requirements as of December 31, 2020?",I don't know.,"First Hawaiian, Inc. is required to maintain minimum amounts and ratios of Common Equity Tier 1 (CET1) capital, Tier 1 capital, and total capital to risk-weighted assets, as well as a minimum leverage ratio. As of December 31, 2020, the Company was classified as well-capitalized and exceeded the capital conservation buffer.",1.0,0.2885051530222919,0.0
"What measures has First Hawaiian, Inc. taken in response to the COVID-19 pandemic, particularly concerning loan modifications and troubled debt restructurings (TDRs)?","First Hawaiian, Inc. implemented several measures in response to the COVID-19 pandemic, including offering loan modifications and participating in federal relief programs such as the Paycheck Protection Program (PPP) and the Small Business Administration (SBA) lending initiatives. The company provided payment deferrals and forbearance options to customers impacted by the pandemic, and these actions were consistent with guidelines from the federal government and regulatory authorities. 

First Hawaiian also recorded a significant increase in troubled debt restructurings (TDRs) in 2020, primarily due to the economic impact of the pandemic, with a focus on residential real estate, commercial real estate, and consumer loans. These restructurings were often short-term modifications, including payment deferrals and rate reductions, and were classified as TDRs under accounting standards if the modifications were deemed to be economically significant or if the borrower was experiencing financial hardship.

For detailed and specific information, including financial impacts and regulatory disclosures, please refer to First Hawaiian, Inc.'s annual reports and SEC filings from 2020 and 2021.","In response to the COVID-19 pandemic, First Hawaiian, Inc. adopted provisions of the CARES Act and Interagency Statements, which allowed for temporary relief from TDR reporting for certain loan modifications made on a good faith basis in response to borrower impacts from COVID-19.",4.0,0.6795801486128664,1.0
What are the potential risks associated with the company's reliance on third-party manufacturers for Oxbryta and its product candidates?,I don't know.,"Risks include reliance on the third party for regulatory compliance and quality assurance, potential breach or termination of the manufacturing agreement, inability to satisfy ordering requirements as to quality, quantity, and price, and the unwillingness of the third party to extend or renew terms with the company.",1.0,0.234686579528132,0.0
How does the company plan to manage its intellectual property risks?,I don't know.,"The company seeks to protect its proprietary position by filing patent applications in the United States and abroad related to Oxbryta and its product candidates. However, it acknowledges the uncertainty and complexity involved in obtaining and enforcing biopharmaceutical patents.",1.0,0.2455793462857622,0.5
What are the potential risks associated with the company's international operations?,I don't know.,"Risks include compliance with complex and changing laws and regulations, difficulties in obtaining and maintaining regulatory approvals for sales or use of products in various countries, complexities in enforcing intellectual property rights, and financial risks such as longer payment cycles and exposure to foreign currency exchange rate fluctuations.",1.0,0.2652276659288221,0.0
What are the financial implications of the Orphan Drug Designation for Oxbryta in the United States?,"The Orphan Drug Designation for Oxbryta (voxelotor) in the United States provides several financial incentives to the manufacturer, Global Blood Therapeutics (now part of Novartis), including:

1. **Tax Credits**: The company is eligible for tax credits for qualified clinical research expenses incurred during the development of the drug.
2. **User Fee Waivers**: The FDA user fee is waived for the approval of the drug, reducing the cost of the regulatory submission process.
3. **Market Exclusivity**: Upon approval, the drug is granted seven years of market exclusivity, preventing competitors from marketing the same drug for the same indication, which can lead to higher pricing and market share.

These incentives are designed to encourage the development of treatments for rare diseases, such as sickle cell disease, which affect fewer than 200,000 people in the U.S. While the designation does not guarantee approval or lower drug costs, it significantly reduces the financial burden on the manufacturer and supports the commercial viability of Oxbryta.","The Orphan Drug Designation for Oxbryta in the United States provides several financial incentives, including tax credits for qualifying clinical trials, exemption from the PDUFA application fee, and a substantial period of regulatory market exclusivity, which will expire on November 25, 2026.",5.0,0.8425220182524356,1.0
How does the company's dependence on a limited number of customers affect its operating results?,"The company's dependence on a limited number of customers can increase its operating risk, as the loss of a major customer could significantly impact revenue and profitability. This concentration may also limit pricing power and growth potential, making the company more vulnerable to economic or industry-specific downturns affecting those key customers.","The company's operating results are contingent on maintaining LNG, natural gas, steam, and power sales to these customers. The loss of a significant customer could adversely affect operating results.",4.5,0.6665151535287449,1.0
How does the company's limited operating history impact its ability to evaluate business prospects?,"The company's limited operating history restricts its ability to evaluate business prospects because there is insufficient historical data to analyze trends, assess performance, or make reliable projections. This makes it more challenging to predict future outcomes, manage risks, or attract investors who rely on past performance as a basis for decision-making.","The limited operating history provides a less reliable basis for evaluating business prospects, as the company continues to develop policies and procedures and build its team.",4.0,0.8375064012082131,1.0
How did the acquisition of MBT Financial Corp. affect First Merchants Corporation's balance sheet?,I don't know.,"The acquisition of MBT Financial Corp. resulted in the addition of $98,563,000 of goodwill and $16,527,000 of core deposit intangibles to First Merchants Corporation's balance sheet.",1.0,0.2077000058845866,0.0
What are the key components of First Merchants Corporation's defined-benefit pension plans?,I don't know.,"The key components include service costs, interest costs, expected return on plan assets, amortization of prior service costs, and actuarial gains/losses.",1.0,0.21532949863462666,0.0
How does First Merchants Corporation manage its exposure to credit risk in financial instruments?,"First Merchants Corporation manages its exposure to credit risk in financial instruments through a combination of credit policies, risk assessment procedures, collateral requirements, and ongoing monitoring. The corporation evaluates the creditworthiness of counterparties, limits exposure to individual borrowers or counterparties, and may require collateral or guarantees for higher-risk transactions. Additionally, it employs credit risk management systems and maintains reserves for potential credit losses in accordance with accounting standards and regulatory guidelines.","First Merchants Corporation manages its exposure to credit risk by maintaining an allowance for loan losses, conducting regular credit quality reviews, and implementing credit policies and underwriting criteria for all loans.",4.5,0.854827412597652,1.0
What is the primary purpose of the funds held in the trust account?,I don't know.,"The primary purpose of the funds held in the trust account is to be used for completing an initial business combination with a target business. If a business combination is not completed within the specified time frame, the funds are to be distributed to public stockholders.",1.0,0.23622344420770908,1.0
What are the potential risks associated with the ability of public stockholders to redeem their shares for cash?,"The potential risks associated with the ability of public stockholders to redeem their shares for cash include:

1. **Capital Drain**: Redemption requests can lead to a significant outflow of capital from the company, potentially weakening its financial position and reducing its ability to invest in growth or operations.

2. **Liquidity Pressure**: If a large number of shareholders request redemption simultaneously, the company may face liquidity challenges, especially if it does not have sufficient cash reserves to meet these demands.

3. **Market Volatility**: High redemption activity may signal investor dissatisfaction, leading to a decline in the stock price and increased market volatility, which can affect the company's valuation and investor confidence.

4. **Dilution of Ownership**: In some cases, redemptions may result in the issuance of new shares to accommodate the remaining shareholders, which could dilute the ownership stake of existing investors.

5. **Loss of Control**: In certain structures, such as special purpose acquisition companies (SPACs), redemptions can result in a loss of control for the management team or sponsors if the company is dissolved or forced to restructure.

6. **Reputation Risk**: Frequent redemptions may be perceived as a sign of underlying problems with the company’s performance or governance, damaging its reputation among investors and stakeholders.

7. **Operational Disruption**: If redemptions force the company to liquidate assets or cut back on operations to raise cash, it could impact long-term strategic goals and operational efficiency.

These risks highlight the importance of careful structuring and management of share redemption mechanisms.","The potential risks include making the company's financial condition unattractive to potential business combination targets, difficulty in entering into an initial business combination with a target, and the possibility of not meeting certain closing conditions if too many public stockholders exercise their redemption rights.",4.0,0.6528487794788334,1.0
What are the implications of the company being deemed an investment company under the Investment Company Act?,"Being deemed an investment company under the Investment Company Act of 1940 subjects the company to significant regulatory requirements, including:

1. **Registration**: The company must register with the Securities and Exchange Commission (SEC) as an investment company.
2. **Structure and Operations**: It must comply with strict rules regarding its organizational structure, governance, and operations, including limits on leverage and concentration of investments.
3. **Prohibited Activities**: It is restricted from engaging in certain activities that could be seen as speculative or potentially harmful to investors, such as excessive trading or using high levels of debt.
4. **Disclosure Requirements**: The company must provide detailed and ongoing disclosures to investors, including financial statements, portfolio holdings, and risk factors.
5. **Investor Protections**: It must adhere to rules designed to protect investors, such as fair pricing of fund shares, limitations on management fees, and requirements for independent directors.
6. **Proxy Rules**: Shareholder voting rights and proxy solicitation rules apply, including the need for shareholder approval for certain matters.

These requirements are intended to ensure transparency, fairness, and investor protection in the investment management industry.","If the company is deemed an investment company, it may be subject to burdensome compliance requirements, restrictions on the nature of its investments, and limitations on the issuance of securities, which could make it difficult to complete an initial business combination and could result in its liquidation.",4.5,0.7326228442748862,1.0
What is the primary responsibility of KeyCorp's management in relation to the financial statements?,The primary responsibility of KeyCorp's management in relation to the financial statements is to prepare and present the financial statements in accordance with generally accepted accounting principles (GAAP) and to ensure their fairness and accuracy. This includes maintaining adequate internal controls over financial reporting.,"KeyCorp's management is responsible for the preparation, content, and integrity of the financial statements and other statistical data compiled for the annual report.",5.0,0.865147336932288,1.0
What is the role of the Audit Committee in KeyCorp's financial reporting process?,"The role of the Audit Committee in KeyCorp's financial reporting process is to oversee the company's financial reporting, internal controls, and compliance with legal and regulatory requirements. The Audit Committee is responsible for appointing, compensating, and overseeing the work of the independent auditor, reviewing the financial statements, and ensuring the integrity of the financial reporting process. It also monitors the effectiveness of internal controls and reviews the results of audits performed by internal and external auditors. The committee reports directly to the Board of Directors.","The Audit Committee meets regularly with Management, internal audit, and the independent registered public accounting firm to review the scope of their audits and discuss the evaluation of internal accounting controls and financial reporting matters.",5.0,0.5987640482906114,1.0
How does KeyCorp assess the effectiveness of its internal control over financial reporting?,"KeyCorp assesses the effectiveness of its internal control over financial reporting through a comprehensive process that includes ongoing monitoring, periodic testing, and annual evaluation. This process involves management's assessment, supported by internal audit and external audit reviews, in accordance with the requirements of the Sarbanes-Oxley Act and the standards of the Public Company Accounting Oversight Board (PCAOB). The company's management, including the Chief Executive Officer and Chief Financial Officer, certifies the effectiveness of internal controls annually in its filings with the SEC. Additionally, KeyCorp relies on its internal audit function to conduct independent assessments and provide recommendations for improvement. The Board of Directors and its Audit Committee oversee this process to ensure accountability and effectiveness.","KeyCorp assesses the effectiveness of its internal control over financial reporting using criteria described in ""Internal Control - Integrated Framework"" issued by the Committee of Sponsoring Organizations of the Treadway Commission (2013 framework).",4.0,0.7654669455062117,1.0
What was the impact of adopting ASU 2016-13 on KeyCorp's financial statements?,I don't know.,"The adoption of ASU 2016-13 resulted in a $230 million decrease in retained earnings as of January 1, 2020, net of deferred taxes of $71 million, for the cumulative effect of adopting the new accounting standard for expected credit losses.",1.0,0.23362936649460306,0.0
What is the significance of the allowance for loan and lease losses (ALLL) in KeyCorp's financial statements?,"The allowance for loan and lease losses (ALLL) in KeyCorp's financial statements represents the amount the company has set aside to cover expected loan losses. It is a key indicator of the bank's credit risk management and financial health, reflecting its assessment of potential defaults on loans and leases. The ALLL helps ensure that the bank's financial statements reflect a realistic valuation of its loan portfolio and maintains capital adequacy by preparing for potential loan losses. Changes in the ALLL can impact net income and affect investors' perceptions of the bank's risk profile.","The ALLL represents KeyCorp's current estimate of lifetime credit losses inherent in the loan portfolio at the balance sheet date, which is a critical component in reflecting the expected credit losses in the financial statements.",5.0,0.7426809589727477,1.0
How does KeyCorp manage its exposure to credit risk on derivative contracts?,"KeyCorp manages its exposure to credit risk on derivative contracts through a combination of collateral requirements, netting agreements, and counterparty credit assessments. The company monitors counterparty creditworthiness, requires collateral (such as cash or securities) when appropriate, and uses netting arrangements to reduce exposure. Additionally, KeyCorp employs internal risk management policies and limits on exposure to individual counterparties to mitigate potential losses.","KeyCorp mitigates credit risk on derivative contracts by entering into bilateral collateral and master netting agreements that allow for the net settlement of all contracts with a single counterparty in the event of default, and by monitoring counterparty credit risk exposure.",5.0,0.8119199691739706,1.0
What are the key components of KeyCorp's deferred tax assets and liabilities?,I don't know.,"KeyCorp's deferred tax assets and liabilities are determined based on temporary differences between financial statement asset and liability amounts and their respective tax bases, and are measured using enacted tax laws and rates expected to apply in the periods in which the deferred tax assets or liabilities are realized.",1.0,0.2889108609760452,0.0
How have the COVID-19 pandemic and government measures impacted the company's operations?,I don't know.,"The COVID-19 pandemic has caused disruptions in operations, including delays in clinical trials, difficulties in patient enrollment, and potential impact on the cost and timelines of the Phase 3 program.",1.0,0.3077496274718076,0.0
What are the potential risks associated with relying on third-party manufacturers for the production of ensifentrine?,"Relying on third-party manufacturers for the production of ensifentrine may pose several potential risks, including:

1. **Quality Control Issues**: Third-party manufacturers may not adhere to the same stringent quality standards as the original developer, leading to variability in drug potency, purity, or safety.

2. **Supply Chain Disruptions**: Dependence on external manufacturers introduces vulnerabilities related to raw material availability, production delays, or logistical challenges.

3. **Intellectual Property Risks**: Sharing manufacturing processes or formulations with third parties could expose proprietary knowledge, potentially leading to unauthorized replication or misuse.

4. **Regulatory Non-Compliance**: If the third party fails to meet regulatory requirements (e.g., FDA, EMA), it could result in product recalls, delays in approvals, or legal liabilities.

5. **Consistency and Scalability**: Inconsistent production processes or limited capacity may hinder the ability to scale up production efficiently to meet demand.

6. **Reputation Risk**: Any quality or safety issues arising from third-party manufacturing could damage the brand's reputation and erode consumer trust.

7. **Loss of Control**: Reduced oversight over manufacturing processes may limit the parent company's ability to quickly respond to issues or implement changes.

These risks emphasize the importance of rigorous due diligence, strong contractual agreements, and ongoing monitoring when working with third-party manufacturers.","Risks include potential delays in supply, quality control issues, and the possibility of third-party manufacturers failing to comply with regulatory requirements, which could delay or prevent the commercialization of ensifentrine.",5.0,0.8179022518386608,1.0
How did the COVID-19 pandemic affect South State Corporation's operations and financial results in 2020?,I don't know.,"The COVID-19 pandemic led to increased provisions for credit losses, changes in customer behavior affecting deposit and loan activities, and operational challenges such as branch closures and remote work setups, which collectively impacted financial results and operational efficiency in 2020.",1.0,0.27019993097463585,0.0
What measures did South State Corporation implement in response to the COVID-19 pandemic to support its customers and maintain operational continuity?,I don't know.,"South State Corporation implemented loan modification programs, payment deferrals, and fee waivers for affected customers. Internally, the bank closed banking lobbies, moved to drive-thru and online services, and allowed non-customer-facing employees to work from home to ensure operational continuity.",1.0,0.2731335179546955,0.0
"How did South State Corporation's capital adequacy ratios change post-merger with CSFL, and what factors influenced these changes?",I don't know.,"Post-merger, South State Corporation's capital ratios, particularly the Tier 1 leverage ratio and Tier 1 risk-based capital ratio, decreased due to the significant increase in assets and risk-weighted assets. However, the total risk-based capital ratio increased, influenced by the inclusion of additional Tier 2 capital from subordinated debt and trust preferred securities acquired through the merger.",1.0,0.1540334870254207,0.0
How did the merger with CenterState Bank Corporation (CSFL) impact South State Corporation's loan portfolio at the time of acquisition?,"The merger with CenterState Bank Corporation (CSFL) expanded South State Corporation's loan portfolio significantly, adding approximately $4.2 billion in loans at the time of acquisition in 2018. This acquisition broadened South State's presence in Florida and increased its overall loan portfolio size, contributing to its growth as a regional bank.","The merger with CSFL resulted in South State Corporation acquiring $13.0 billion of loans, including PPP loans, at fair value, net of $239.5 million, or 1.82%, estimated discount to the outstanding principal balance, representing 113.9% of the Company’s total loans at December 31, 2019.",2.0,0.7715479421089947,1.0
What was the impact of the COVID-19 pandemic on South State Corporation's evaluation of goodwill for impairment in 2020?,I don't know.,"South State Corporation evaluated the carrying value of goodwill as of April 30, 2020, considering the effects of COVID-19, and obtained a third-party valuation during the fourth quarter of 2020, concluding that no impairment charge was necessary.",1.0,0.2775701518188358,0.0
What are the potential consequences of the company's failure to maintain REIT qualification?,"The potential consequences of a company's failure to maintain REIT qualification include:

1. **Loss of Tax Advantages**: The company would no longer be exempt from corporate-level income tax, resulting in significant tax liabilities on its income.
2. **Imposition of Corporate Income Tax**: The REIT would be subject to regular corporate income tax on its taxable income, reducing its net income and profitability.
3. **Penalty Taxes**: The company may be subject to excise taxes on certain types of income or transactions that were previously tax-free under REIT rules.
4. **Loss of Investor Appeal**: The company may lose its attractiveness to investors who seek tax-efficient investments, potentially leading to a decline in share price and difficulty in raising capital.
5. **Restoration Costs**: Reinstating REIT status typically requires a five-year waiting period and may involve complex restructuring or compliance measures, leading to operational and financial disruption.
6. **Reduced Distribution Requirements**: The company would no longer be required to distribute at least 90% of its taxable income as dividends, but this may result in higher tax burden and reduced cash flow for shareholders.

These consequences can significantly impact the company's financial performance, governance, and market position.","If the company fails to maintain its REIT qualification, it would be subject to corporate-level income taxes on all of its taxable income, which would significantly reduce the amount of cash available for distribution to shareholders. This could negatively affect the value of its common shares and the sustainability of its business model.",5.0,0.8239293819864395,1.0
How does the company mitigate interest rate risk and what are the potential drawbacks of its hedging strategies?,I don't know.,"The company uses derivative financial instruments, such as swaps, options, and futures, to hedge against interest rate risk. However, these hedging activities can be expensive, may not perfectly correlate with the risks being hedged, and could result in worse overall investment performance if unanticipated changes in interest rates occur.",1.0,0.26739789837486966,0.0
What are the cybersecurity risks the company faces and how could they impact its operations?,I don't know.,"The company faces risks of cyber incidents, including unauthorized access, data breaches, and system disruptions. These could lead to compromised confidential information, operational disruptions, financial losses, litigation, and damage to business relationships, all of which could negatively impact its financial results and reputation.",1.0,0.2780586335039891,0.0
"What is the primary investment objective of Barings BDC, Inc.?","The primary investment objective of Barings BDC, Inc. is to generate current income and, to a lesser extent, capital appreciation for its stockholders.","The primary investment objective of Barings BDC, Inc. is to generate current income by investing directly in privately-held middle-market companies to help these companies fund acquisitions, growth, or refinancing.",4.0,0.9261918537873173,1.0
"What was the total amount of new commitments made by Barings BDC, Inc. subsequent to December 31, 2020?",I don't know.,"Subsequent to December 31, 2020, the Company made approximately $224.1 million of new commitments, of which $202.2 million closed and funded.",1.0,0.24700846195309215,0.5
How did the Company account for the COVID-19 pandemic in its financial statements?,I don't know.,"The Company temporarily closed its retail locations due to the COVID-19 pandemic, which it expects to have an unfavorable impact on its sales, results of operations, and cash flows in fiscal 2020.",1.0,0.2900196457457629,0.0
What was the impact of the adoption of the new lease accounting standard (ASUs) on the Company’s consolidated balance sheet?,I don't know.,"The adoption of the ASUs resulted in the recognition of lease right-of-use assets and corresponding lease liabilities, as well as adjustments to opening retained earnings and other balance sheet items.",1.0,0.20064559934771142,0.0
What were the key factors considered by the Company in determining the fair value of its reporting units for impairment testing?,I don't know.,"The Company considered factors such as revenues, expenses, fixed asset and working capital requirements, the impact of updated tax legislation, and other subjective inputs in determining the fair value of its reporting units.",1.0,0.16480805300679782,0.0
How has the COVID-19 pandemic impacted the company's operations and financial outlook for fiscal 2020?,I don't know.,"The COVID-19 pandemic has significantly disrupted the company's operations, leading to temporary store closures and substantial uncertainty about the timing and manner of returning to normal business operations. The company has withdrawn all prior guidance and outlook statements for fiscal 2020 due to the unpredictable nature of the pandemic's impact.",1.0,0.3228978281106575,0.0
What are the key strategies the company is focusing on to drive growth in its business?,I don't know.,"The company is focusing on several key strategies to drive growth, including transforming its real estate platform, pursuing international expansion, expanding its merchandise assortment and market share, growing its integrated hospitality experience, and architecting a new operating platform to enhance customer experience and operational efficiency.",1.0,0.2060559957779829,0.0
How does the company assess the performance of its business?,I don't know.,"The company assesses the performance of its business using various financial and operating measures, including net revenues, gross profit, selling, general, and administrative expenses, adjusted operating income, adjusted EBITDA, and adjusted net income. These measures help the company evaluate its operating performance consistently over time.",1.0,0.19544859172258966,0.0
"What are the company's primary sources of liquidity, and how has the COVID-19 crisis affected its liquidity position?",I don't know.,"The company's primary sources of liquidity are cash flows from operations, net cash proceeds from the issuance of convertible senior notes, and borrowings under its credit facilities. The COVID-19 crisis has introduced significant uncertainty regarding the company's liquidity requirements and has prompted the company to implement cost-saving measures and negotiate with lenders and landlords to preserve financial flexibility.",1.0,0.23537628164690405,0.0
"How has the company's approach to real estate transformation evolved, and what impact has it had on the business?",I don't know.,"The company has evolved its real estate approach by adopting a multi-tier market strategy, including the development of prototype Design Galleries, larger Bespoke Design Galleries in top metropolitan markets, indigenous Bespoke Galleries in second home markets, and smaller Galleries in secondary markets. This strategy aims to optimize market share and return on invested capital, with recent openings showing positive results in terms of profitability and brand statement.",1.0,0.11599925776619305,0.0
What are the risks associated with the company's reliance on third-party manufacturers for the production of its product candidates?,I don't know.,"The risks include potential delays in manufacturing, quality control issues, and the possibility of the third-party manufacturer failing to meet demand or terminating the relationship, which could impact the company's ability to supply its product candidates for clinical trials or commercialization.",1.0,0.253983739526617,0.0
What are the provisions in the company's corporate charter that could potentially discourage a takeover?,I don't know.,"The company's corporate charter includes provisions such as a classified board of directors, advance notice requirements for stockholder proposals, and a requirement for a supermajority vote to amend certain provisions, which could make a takeover more difficult.",1.0,0.28793939958298204,0.0
What is the significance of the company's exclusive forum provision in its certificate of incorporation?,"The significance of a company's exclusive forum provision in its certificate of incorporation is that it designates a specific court or jurisdiction as the exclusive venue for resolving certain types of legal disputes, typically those related to corporate governance or shareholder rights. This provision can provide legal certainty, reduce litigation costs, and streamline dispute resolution by limiting the courts in which shareholders or other parties may bring claims. It is commonly used to protect the company and its directors from forum shopping and to ensure that disputes are handled in a predictable and efficient manner.","The exclusive forum provision designates the Court of Chancery of the State of Delaware as the sole forum for certain types of actions and disputes between the company and its stockholders, which could limit stockholders' ability to choose a preferred judicial forum for such disputes.",5.0,0.6726614411662614,1.0
What are the potential financial and operational impacts of the company becoming involved in securities class action litigation?,"The potential financial and operational impacts of a company becoming involved in securities class action litigation include:

**Financial Impacts:**
1. **Legal Costs:** Significant expenses related to litigation, including attorney fees, expert witness fees, and discovery costs.
2. **Settlement or Judgments:** The company may be required to pay substantial damages or settlements, which can impact cash flow and financial statements.
3. **Increased Insurance Premiums:** Costs for directors and officers (D&O) liability insurance may rise.
4. **Loss of Investor Confidence:** Stock price declines can reduce market capitalization and make future fundraising more difficult or expensive.

**Operational Impacts:**
1. **Management Distraction:** Executives and legal teams may be diverted from strategic initiatives to focus on litigation.
2. **Regulatory Scrutiny:** Increased attention from regulators, potentially leading to audits, investigations, or enforcement actions.
3. **Reputational Damage:** Negative publicity can harm customer relationships, partnerships, and talent acquisition.
4. **Compliance Enhancements:** The company may need to strengthen internal controls, compliance programs, and governance practices, increasing operational overhead.

These effects can have long-term consequences on the company’s financial health and operational efficiency.","Securities class action litigation could be expensive, divert management's attention and resources, and adversely affect the company's business and financial condition. Insurance coverage may not be sufficient to cover all costs and damages.",5.0,0.7430654776956863,1.0
What are the principal risks related to the economy that could negatively affect the company's portfolio companies and results of operations?,I don't know.,"The principal risks include public health crises, economic recessions, capital market disruptions, and the inability to obtain additional capital due to regulatory or market constraints.",1.0,0.23011878071577696,0.0
"What specific risks are associated with the company's subsidiary, NSBF, being an SBLC licensed by the SBA?",I don't know.,"NSBF must maintain minimum regulatory capital and comply with SBA regulations, including potential liability for SBA guaranty denials or repairs, which could transfer liability to NSBF.",1.0,0.2207224477216119,0.0
"How does the company plan to maintain its tax treatment as a RIC, and what are the potential consequences of failure?",I don't know.,"To maintain RIC status, the company must meet source-of-income, asset diversification, and distribution requirements. Failure could subject the company to corporate-level income tax, reducing net assets and available income for distribution.",1.0,0.19199964775651546,0.0
What are the risks related to the company's investments in technology-related companies?,I don't know.,"Risks include potential obsolescence of intellectual property, equipment, and inventory due to technological advancements, which could impair the collateral value of loans made to these companies.",1.0,0.22123101698933056,0.0
How does the company's status as a BDC affect its ability to raise additional capital and the way it does so?,"As a BDC (Business Development Company), the company is required by law to distribute at least 90% of its taxable income to shareholders in the form of dividends. This structure allows BDCs to raise capital more easily by issuing debt or equity securities, as they can leverage their investment portfolio to secure financing. BDCs also benefit from favorable tax treatment, as they are not subject to corporate income tax if they meet specific requirements. This allows them to raise additional capital more efficiently by offering shareholders attractive dividend yields and accessing public markets.","As a BDC, the company is subject to restrictions on issuing common stock below net asset value and must maintain an asset coverage ratio for senior securities. These constraints affect its capital raising flexibility and methods.",3.0,0.6564741949579356,1.0
How does Newtek Business Services Corp. determine the fair value of its investments?,"Newtek Business Services Corp. determines the fair value of its investments based on observable market inputs, such as quoted prices in active markets for identical assets, and uses valuation techniques like the income approach, market approach, and cost approach. These methods are applied in accordance with accounting standards such as ASC 820 (Fair Value Measurement). The company relies on quoted market prices for Level 1 assets, quoted prices for similar assets in active markets for Level 2, and unobservable inputs for Level 3 assets, where applicable. The fair value measurements are regularly reviewed and updated to reflect current market conditions.","Newtek Business Services Corp. determines the fair value of its investments using unobservable inputs and assumptions, classifying them as Level 3 within the fair value hierarchy. This involves significant judgments about valuation methodologies and inputs such as revenue and EBITDA multiples, market yields, discounts for lack of marketability, underlying cash flows, and the impact of economic conditions.",3.0,0.8921278418271571,1.0
What critical audit matter was communicated regarding the valuation of investments?,I don't know.,"The critical audit matter communicated was the valuation of investments, which involves judgments necessary for management to select and apply valuation techniques and assumptions, the high degree of auditor judgment involved, and the extensive audit effort involved in testing the valuations.",1.0,0.29074986617163645,0.5
What is the total principal amount of PPP loans funded by NSBF during the duration of the PPP?,I don't know.,"NSBF funded approximately 10,570 PPP loans totaling $1.19 billion during the duration of the PPP.",1.0,0.21266210458578583,1.0
How does the CARES Act affect existing SBA 7(a) borrowers?,"The CARES Act allows existing SBA 7(a) borrowers who received loans before April 3, 2020, to defer principal and interest payments for six months without penalty or fees. This deferment applies to loans made under the 7(a) program, including those made under the Economic Injury Disaster Loan (EIDL) program and the Paycheck Protection Program (PPP), if the loan was used for eligible purposes. The deferment helps borrowers manage cash flow during the COVID-19 pandemic.","The CARES Act provided an over $2.0 trillion stimulus package, including subsidies to certain existing SBA 7(a) borrowers where the SBA paid all principal, interest, and fees on existing performing SBA 7(a) loans for six months beginning with such borrowers’ April 2020 payments.",3.0,0.7759564811299344,1.0
How does Newtek Business Services Corp. account for its equity-based compensation plan?,"Newtek Business Services Corp. accounts for its equity-based compensation plan under the fair value method in accordance with Accounting Standards Codification (ASC) 718, ""Compensation – Stock Compensation."" This involves recognizing the fair value of stock options and other equity-based awards as compensation expense over the vesting period. The fair value is typically determined using the Black-Scholes model or a lattice-based model for complex awards. The expense is recognized over the service period, and any estimated forfeitures are factored into the calculation. I don't know if there are specific nuances in Newtek's accounting policies beyond this general framework.","Newtek Business Services Corp. accounts for its equity-based compensation plan using the fair value method, as prescribed by ASC 718. For restricted stock awards, the Company measures the grant date fair value based upon the market price of its common stock on the date of the grant and amortizes this fair value to salaries and benefits over the requisite service period.",4.0,0.6921983277751711,1.0
How does Fusion plan to address the risk of third-party claims of intellectual property infringement?,"Fusion plans to address the risk of third-party claims of intellectual property infringement by implementing a comprehensive strategy that includes thorough intellectual property due diligence, licensing agreements with clear rights and obligations, regular monitoring of intellectual property landscapes, and legal defense mechanisms. Additionally, Fusion may obtain indemnification from vendors and partners, maintain insurance coverage for IP claims, and establish internal protocols to ensure compliance with intellectual property laws. These measures help mitigate potential risks and protect the company's operations and reputation.","Fusion plans to manage this risk by ensuring compliance with patent laws and regulations, potentially obtaining licenses when necessary, and defending against any claims through legal proceedings if needed.",5.0,0.7540941872874769,1.0
How does Fusion mitigate the risk of product liability claims?,"Fusion mitigates the risk of product liability claims by implementing rigorous design, testing, and quality control processes, ensuring compliance with industry standards and regulations, maintaining comprehensive documentation, and providing clear product instructions and warnings. Additionally, Fusion may utilize insurance coverage and contractual indemnification to further reduce exposure to liability.","Fusion mitigates this risk by maintaining product liability insurance, ensuring strict quality control in manufacturing, and adhering to regulatory standards in the development and marketing of its products.",5.0,0.8661369207150101,1.0
What is the primary focus of the company's business?,I don't know.,"The company is a clinical-stage oncology company focused on developing next-generation radiopharmaceuticals as precision medicines, particularly through its Targeted Alpha Therapies (TAT) platform.",1.0,0.19017139395307137,0.5
"What strategic collaboration has the company entered into, and what are the key terms of this collaboration?",I don't know.,"The company has entered into a strategic collaboration agreement with AstraZeneca to jointly discover, develop, and commercialize next-generation alpha-emitting radiopharmaceuticals and combination therapies for the treatment of cancer. The collaboration leverages Fusion’s TATs platform and expertise in radiopharmaceuticals with AstraZeneca’s leading portfolio of antibodies and cancer therapeutics, including DDRis. Both companies will retain full rights to their respective assets.",1.0,0.20354981150174992,0.0
How does the company plan to address the potential for reduced profitability due to government and third-party payor reimbursement policies?,I don't know.,"The company must engage in a time-consuming and costly process to provide scientific and clinical support for the use of its products to each payor separately, with no assurance that coverage and adequate reimbursement will be obtained. The company may also need to negotiate lower prices for its products to be covered by government health programs and commercial insurance, which could impact profitability.",1.0,0.26331960425998074,0.5
What is the company's approach to intellectual property protection for its products and technologies?,I don't know.,"The company seeks to protect its products and technologies by filing U.S. and foreign patent applications related to its proprietary technology, inventions, and improvements. It also relies on trade secrets, know-how, continuing technological innovation, and in-licensing of third-party intellectual property to develop and maintain its proprietary position.",1.0,0.249306887907143,0.0
What significant changes did Jefferies Financial Group Inc. make to its operating segments in the first quarter of 2020?,I don't know.,"In the first quarter of 2020, Jefferies Financial Group Inc. appointed co-Presidents of Asset Management and created a separate operating segment for asset management activities previously included in the Investment Banking, Capital Markets, and Asset Management segment, as well as those previously included in the Merchant Banking segment.",1.0,0.22451829743220245,0.0
How does Jefferies Financial Group Inc. manage its exposure to credit risk associated with derivative activities and securities financing transactions?,"Jefferies Financial Group Inc. manages its exposure to credit risk associated with derivative activities and securities financing transactions through a combination of credit risk management practices, including collateral requirements, netting agreements, and ongoing monitoring of counterparty creditworthiness. The company requires collateral (such as cash or securities) from counterparties to mitigate risk, often using master agreements like the ISDA (International Swaps and Derivatives Association) framework, which includes netting and collateralization provisions. Additionally, Jefferies employs internal credit limits, stress testing, and regular risk assessments to monitor and control its exposure. The company also engages in credit risk assessment and ongoing monitoring of counterparties, adjusting collateral requirements as necessary based on market conditions and credit ratings.","Jefferies Financial Group Inc. manages its exposure to credit risk through master netting agreements, master securities lending agreements, master repurchase agreements, or similar agreements and collateral arrangements with counterparties. These agreements provide protection in bankruptcy in certain circumstances and enable receivables and payables with the same counterparty to be settled or otherwise eliminated by applying amounts due against all or a portion of an amount due from the counterparty or a third-party.",4.5,0.734861748108266,1.0
What is the significance of the foreign currency translation adjustments in Jefferies Financial Group Inc.'s financial statements?,I don't know.,Foreign currency translation adjustments result from translating the financial statements of foreign subsidiaries from their functional currency into the reporting currency (U.S. dollars). These adjustments are included in accumulated other comprehensive income (loss) and can significantly impact the company's equity and financial position.,1.0,0.20301485420294432,0.0
How does SuRo Capital Corp value its investments at fair value?,"SuRo Capital Corp values its investments at fair value using observable market data, such as quoted prices in active markets for identical assets, when available. For investments where quoted prices are not available, it employs valuation techniques such as discounted cash flow models, market comparables, or other appropriate methods that reflect the assumptions market participants would use in pricing the assets. These valuations are performed in accordance with accounting standards (e.g., ASC 820) and may involve input from third-party valuation specialists. The fair value measurements are categorized into a three-level hierarchy based on the observability of inputs.","SuRo Capital Corp values its investments at fair value using a hierarchy that prioritizes the inputs to valuation techniques. Level 1 assets are valued based on unadjusted quoted prices in active markets for identical assets. Level 2 assets use observable inputs other than Level 1 prices, such as quoted prices for similar assets or liabilities. Level 3 assets use unobservable inputs that reflect management’s best estimate of what market participants would use in pricing the asset or liability.",4.0,0.82372742116627,1.0
What measures has SuRo Capital Corp taken to ensure compliance with the RIC tax provisions of the Code?,"SuRo Capital Corp has implemented various measures to ensure compliance with the RIC (Regulated Investment Company) tax provisions of the Internal Revenue Code, including maintaining a diversified portfolio, adhering to income and asset diversification requirements, and regularly monitoring compliance with the Code's provisions. Specific details are typically outlined in their annual reports or filings with the SEC. For precise and up-to-date information, refer to their public filings, such as the annual Form 10-K or other regulatory disclosures.",SuRo Capital Corp has elected to be treated as a RIC under Subchapter M of the Code and intends to qualify for tax treatment as a RIC. The Company is required to meet certain income and asset diversification tests and distribute dividends of an amount generally at least equal to 90% of its investment company taxable income to its stockholders. The Company has taxable subsidiaries that hold certain portfolio investments to limit potential legal liability and comply with source-income type requirements.,4.0,0.7423925213962648,1.0
What are the key features of Waste Management's Employee Stock Purchase Plan (ESPP)?,I don't know.,"The key features of Waste Management's ESPP include employees being able to purchase shares of common stock at a discount, with purchases made at the end of offering periods with funds accumulated through payroll deductions. The discount is 85% of the lesser of the market value of the stock on the first and last day of the offering period.",1.0,0.2910127351723552,0.0
How does Waste Management assess and manage its long-lived assets for potential impairment?,"Waste Management assesses and manages its long-lived assets for potential impairment by regularly evaluating the recoverability of the carrying value of these assets. This process involves comparing the carrying amount of the assets to their undiscounted future cash flows. If the carrying amount exceeds the expected future cash flows, an impairment loss is recognized. The impairment loss is measured as the difference between the carrying amount and the fair value of the asset. Waste Management conducts these assessments at least annually or whenever events or changes in circumstances indicate that the carrying amount of an asset may not be recoverable. The company follows the guidelines provided by the Financial Accounting Standards Board (FASB) under U.S. Generally Accepted Accounting Principles (GAAP).","Waste Management assesses its long-lived assets for potential impairment by monitoring the carrying value for potential impairment indicators. If an impairment indicator occurs, the company performs a test of recoverability by comparing the carrying value of the asset or asset group to its undiscounted expected future cash flows. If the carrying value exceeds the undiscounted cash flows, the company measures the impairment by comparing the fair value of the asset or asset group to its carrying value.",5.0,0.8505139011926378,1.0
"What are the primary sources of revenue for Waste Management, and how do they contribute to the overall revenue mix?","The primary sources of revenue for Waste Management, Inc. include residential waste collection, commercial waste collection, industrial waste services, recycling services, and landfill operations. 

Residential waste collection contributes significantly to the overall revenue mix, as it involves regular service contracts with households. Commercial waste collection, serving businesses and institutions, is another major revenue driver due to higher volume and frequency of pickups. Recycling services generate income through the collection, processing, and sale of recyclable materials, while also supporting the company's sustainability initiatives. Landfill operations contribute through tipping fees charged for the disposal of waste.

Together, these segments create a diversified revenue stream, with waste collection and landfill operations being the dominant contributors to the company’s overall revenue. The specific mix can vary by region and market demand, but waste collection (residential and commercial) typically accounts for the largest share, followed by landfill operations and recycling services.","The primary sources of revenue for Waste Management are collection, landfill, transfer, and recycling services. These services contribute to the overall revenue mix, with collection and landfill services typically being the most significant contributors.",4.5,0.8944764806145483,1.0
"How does Waste Management handle its environmental remediation liabilities, and what was the total amount of such liabilities as of December 31, 2020?","Waste Management handles its environmental remediation liabilities through a combination of financial reserves, remediation projects, and compliance with regulatory requirements. The company establishes reserves based on assessments of sites requiring cleanup, considering factors such as the scope of contamination, remediation costs, and legal obligations. These reserves are periodically reviewed and updated based on new site evaluations or changes in regulatory standards.

As of December 31, 2020, the total amount of Waste Management's environmental remediation liabilities was $1.4 billion.","Waste Management handles its environmental remediation liabilities by recognizing and accruing for an estimated remediation liability when it determines that such liability is both probable and reasonably estimable. The total amount of environmental remediation liabilities as of December 31, 2020, was $230 million.",3.0,0.8631311167885181,1.0
"What are the key financial covenants associated with Waste Management's debt agreements, and how does the company ensure compliance?",I don't know.,"The key financial covenant associated with Waste Management's debt agreements is the maximum total debt to consolidated earnings before interest, taxes, depreciation, and amortization (EBITDA) ratio (the ""Leverage Ratio""). The company ensures compliance by monitoring its financial position and maintaining significant headroom within the Leverage Ratio.",1.0,0.15013257647595574,0.0
How does ridinilazole aim to differentiate itself from existing treatments for CDI?,"Ridinilazole aims to differentiate itself from existing treatments for *Clostridioides difficile* infection (CDI) by selectively targeting the pathogen while sparing the beneficial gut microbiota. Unlike broad-spectrum antibiotics such as vancomycin and fidaxomicin, which can disrupt the gut microbiome and increase the risk of recurrent CDI, ridinilazole is designed to have a narrow spectrum of activity. This targeted approach helps preserve the normal gut flora, potentially reducing the risk of recurrence and improving long-term patient outcomes.","Ridinilazole is designed to selectively target the bacterium Clostridioides difficile while preserving the gut microbiome, potentially reducing recurrence rates and improving sustained clinical response rates compared to broad-spectrum antibiotics like vancomycin.",5.0,0.8836129506942729,1.0
What financial support has Summit Therapeutics received for the development of ridinilazole?,"Summit Therapeutics has received financial support for the development of ridinilazole through a combination of research grants, venture capital funding, and partnerships. Specifically, the company has secured funding from organizations such as the Biomedical Advanced Research and Development Authority (BARDA), a U.S. Department of Health and Human Services agency, which has provided grants to support the development of ridinilazole for the treatment of *Clostridioides difficile* infection (CDI). Additionally, Summit Therapeutics has raised capital through public and private investments to fund clinical trials and research activities. For precise figures and amounts, detailed financial disclosures or regulatory filings would need to be consulted.",Summit Therapeutics has received a contract from the Biomedical Advanced Research and Development Authority (BARDA) worth up to $72.5 million to support the ongoing Phase 3 clinical trials and potential regulatory applications for ridinilazole in the United States.,4.0,0.752495138640217,1.0
What are the key competitive factors affecting the success of Summit Therapeutics' product candidates?,I don't know.,"The key competitive factors include efficacy, safety, convenience, price, and the availability of coverage and reimbursement from government and other third-party payors.",1.0,0.18610799570560024,0.0
"What are the potential risks associated with the company's reliance on government funding for its lead product candidate, ridinilazole?",I don't know.,"Risks include the possibility of the government terminating the funding contract, changes in government budgets and research priorities, delays in development activities, and increased costs of commercialization and production due to imposed requirements. These factors could force the company to seek alternative funding sources, which may not be available on favorable terms.",1.0,0.23177994930702314,0.0
What are the key factors that contributed to the increase in net interest income during 2020?,I don't know.,"The increase in net interest income during 2020 was primarily due to lower interest expense from interest-bearing liabilities driven by lower rates paid and a shift in mix to lower cost deposits, as well as the favorable impact of higher average interest earning asset balances.",1.0,0.20779277479645505,0.0
How did the COVID-19 pandemic impact the provision for credit losses in 2020?,"The COVID-19 pandemic significantly impacted the provision for credit losses in 2020, leading to a substantial increase in provisions across the banking sector. This was driven by heightened economic uncertainty, widespread job losses, business closures, and a decline in consumer spending, which increased the risk of loan defaults. In response, banks and financial institutions increased their loan loss provisions to account for higher expected credit losses under the CECL (Current Expected Credit Loss) accounting standard, which requires institutions to estimate and reserve for expected losses over the life of a loan. The increase in provisions resulted in lower net income for many banks during the year, reflecting the economic fallout of the pandemic.","The COVID-19 pandemic significantly impacted the provision for credit losses in 2020 by causing a deterioration of economic conditions, which resulted in a worsening of the economic forecasts used for calculating expected credit losses and downgrades reflecting weakness in the financial condition of certain clients.",5.0,0.6543001950895447,1.0
What measures were taken by HSBC USA to manage liquidity and funding risk during the COVID-19 pandemic?,"During the COVID-19 pandemic, HSBC USA implemented a range of measures to manage liquidity and funding risk, including:

1. **Strengthening Liquidity Position**: HSBC USA maintained robust liquidity buffers, including a high level of high-quality liquid assets (HQLA), to ensure the ability to meet short-term obligations under stress.

2. **Enhanced Stress Testing**: The bank conducted regular stress tests to assess its liquidity and funding resilience under various pandemic-related scenarios, ensuring preparedness for potential shocks.

3. **Centralized Liquidity Management**: HSBC reinforced its centralized liquidity management framework to monitor and manage liquidity across the organization, including funding sources and maturities.

4. **Diversification of Funding Sources**: The bank diversified its funding base by increasing reliance on stable sources such as customer deposits and secured funding, reducing dependence on wholesale funding markets.

5. **Active Management of Funding Maturity Profile**: HSBC USA managed the maturity profile of its funding to avoid concentration risk and ensure adequate funding continuity.

6. **Collaboration with Group Liquidity Functions**: The bank coordinated closely with HSBC Group’s global liquidity and funding teams to access group-wide liquidity resources and support during periods of stress.

7. **Regulatory Compliance and Reporting**: The bank ensured compliance with regulatory requirements, including those set by the Federal Reserve and the Office of the Comptroller of the Currency (OCC), and maintained regular reporting on liquidity and funding risk metrics.

8. **Operational Continuity Planning**: HSBC implemented business continuity plans to ensure uninterrupted access to liquidity and funding mechanisms, including remote working arrangements and technology resilience.

These measures helped HSBC USA maintain financial stability and support its customers and operations during the pandemic.","During the COVID-19 pandemic, HSBC USA actively raised deposits, increased short-term borrowings in the form of securities sold under repurchase agreements, and borrowed from the Federal Home Loan Bank to support elevated client demand for loans while maintaining adequate liquidity.",4.5,0.7300718137346762,1.0
What was the impact of the LIBOR transition on HSBC USA's operations?,"The LIBOR transition had a significant impact on HSBC USA's operations, requiring the bank to overhaul its systems, processes, and contracts to transition from LIBOR to alternative reference rates, such as SOFR (Secured Overnight Financing Rate). This involved extensive collaboration with clients, counterparties, and regulators to amend financial products, including loans, derivatives, and bonds. HSBC USA also implemented technology upgrades, updated risk management frameworks, and conducted extensive training to ensure compliance with new benchmarks and regulatory requirements. The transition aimed to maintain market stability and minimize disruptions to customers and the broader financial system.","The LIBOR transition process involved developing alternative rate product capabilities and transitioning legacy contracts. This transition could have a range of adverse impacts on HSBC USA's business, including legal proceedings or other actions regarding the interpretation and enforceability of provisions in LIBOR contracts and regulatory investigations or reviews.",4.5,0.7391294760281449,1.0
How did HSBC USA manage its credit risk during the economic uncertainty caused by the COVID-19 pandemic?,"During the economic uncertainty caused by the COVID-19 pandemic, HSBC USA managed its credit risk through a combination of prudent lending practices, enhanced risk monitoring, and regulatory compliance. The bank strengthened its credit underwriting standards, increased provisioning for potential loan losses, and conducted stress testing to assess resilience under adverse economic scenarios. HSBC also worked closely with customers to provide loan restructuring and deferral options where appropriate, helping to mitigate defaults. Additionally, the bank maintained strong capital and liquidity positions, ensuring it could withstand economic shocks. These measures helped HSBC USA maintain financial stability and manage credit risk effectively during the pandemic.","HSBC USA managed its credit risk during the pandemic by re-reviewing the credit ratings assigned to substantially all of its material commercial loans, closely monitoring the performance of these loans, and taking necessary credit actions where warranted.",4.5,0.7713476116027297,1.0
"What was the strategic plan announced by HSBC USA in February 2020, and what were its expected financial impacts?","In February 2020, HSBC USA announced a strategic plan aimed at simplifying its U.S. business and improving profitability. The plan included closing 130 retail branches, reducing its U.S. retail footprint by 20%, and shifting focus to high-growth areas such as wealth management, commercial banking, and capital markets. The goal was to reduce costs and improve returns on capital.

Expected financial impacts included annual cost savings of $400 million by the end of 2021, a significant reduction in expenses related to branch operations, and a stronger focus on more profitable segments. The plan was designed to make the U.S. business more resilient and better positioned for long-term growth.","The strategic plan announced in February 2020 aimed to restructure operations in alignment with HSBC’s global strategy, focusing on refocusing wholesale operations and restructuring retail operations. The expected financial impact included pre-tax charges of approximately $520-$590 million over the two-year period of 2020-2021.",4.0,0.7414752062898092,1.0
